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The dental pulp of adult teeth contains a very active stem cell population with a neural 
crest (NC) cell phenotype, termed dental pulp stem cells (DPSCs). Human DPSCs (hDPSCs) 
present substantial advantages compared to other stem cell types that can be found in the adult 
human body, such as a much higher accessibility than endogenous neural stem cells, big 
capacity of ex-vivo expansion, basal expression of a wide variety of neural cell markers and 
subsequent neural differentiation, leaving the door open to neuroregenerative autologous cell 
therapy.  The common proliferative and maintaining culture mediums are composed of fetal 
bovine serum (FBS) that leads fastest growth of hDPSC as well as surface-adherent cell 
monolayer generation. However, the use of FBS is not compatible with the clinical employment 
of these protocols as far as it is the cause of allergies and immune reaction in grafts in vivo. 
Furthermore, several authors have related the presence of serum with the differentiation toward 
mesenchymal cell lineages, and hence, the reduction of neurogenic capacity of hDPSCs. All 
these inconveniences have challenged the scientific society to design and improve new 
innovative serum-free neural inductive protocols.  
In the present work, we wanted to characterize the phenotypic properties of adult 
hDPSCs cultured in serum free mediums. Our results confirmed that non-engineered and non-
modified adult DPSCs cultured in different serum-free mediums were able to generate 
neurosphere-like structures, singular structures generated by neural stem cells (NSCs), called 
dentospheres. Furthermore, we noticed the basal expression of early neural markers, the remain 
of mesenchymal stem cell being and the pluripotential character of DPSCs both in serum-free 
medium and serum containing mediums. However, each specific serum-free culture medium 
provide different unique features to hDPSCs. Thus, when hDPSCs were grown in Neurocult™ 
differentiation neurogenic induction media, a cell culture medium without serum routinely used 
for the differentiation of adult neural stem cells, we showed the neurogenic potential of hDPSCs 
by the expression of mature neuronal and glial markers. In addition, we also described for the 
first time non-engineered and non-modified hDPSCs expressing vascular endothelial cell 
marker CD31, as well as stem mesenchymal and neural early markers in the hDPSCs cultured in 
Neurocult™ proliferation maintaining media. Surprisingly, 1 month post-intracranial graft into 
athymic nude mice these CD31+, Nestin+ cells were located within brain blood vessels 
increasing their laminin expression and co-existing together with murine vascular endothelial 
cells.  
On the other hand, hDPSCs were cultured in a commercial specific mesenchymal stem 
cell culture medium: StemPro MSCTM (STP). Taking advantage of the molecular and 
physiological profits provide by this medium, we observed an increase of NC cell and 
pluripotential markers expression as well as higher neurogenic potential of hDPSCs, that 
suggest a step back to Neural crest stem cells (NCSCs)- like phenotype. 
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Our results demonstrate the possibility of employment serum-free mediums to culture hDPSCs. 
Indeed, not only was avoid the serum associated issues, but it was achieved the activation of 
neural crest stem/progenitor cell character that facilitate the differentiation toward neural 
lineages. Moreover, unexpectedly, we are the first group that discovered an efficient way to 
obtain functional, they showed histo-integration and capacity to generate neovasculature in vivo, 
endothelial cells from hDPSCs in serum-free conditions.  
To sum up, in this work are clarified the doubts that serum-free cultures may produce; such as, 
those related with cell viability and stem being switch, the neurogenic potential of hDPSCs and 
the integration of these cells in live systems have been widely studied. We conclude that the 
neurogenic potential and newly discovered endothelial potential among the other characteristics 
aforementioned convert hDPSCs in a real option to use as a stem cell source for 
neuroregenerative therapies.  
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Aβ = Amyloid beta  
AD = Alzheimer´s disease 
AT-MSCs= Adipose tissue mesenchymal stem cells 
bFGF= fibroblast growth factor  
BME= b-mercaptoethanol  
BDNF= Brain derived neurotrophic factor  
BHA = Butylated hydroxyanisole 
BMPxxx= Bone morphogenetic proteinxxx 
BM-MSCs= Bone marrow mesenchymal stem cells 
CCl4= Carbon tetrachloride  
CDxxx= Cluster Differentiation 
CLECs = Cord lining epithelial cells 
CLMCs= Cord lining mesenchymal cells  
CNS= Central Nervous System 
CT1= Cardiotrophin-1  
DA= Dopaminergic   
DARPP = Cyclic AMP regulated phosphoprotein  
DFSCs= Dental follicule stem cells 
DMEM= Dubbelco´s modified eagle´s medium 
DMP1= Dentin matrix protein 1  
DMSO= Dimethylsulfoxide 
DSPP = Dentin sialophosphoprotein  
ECCs= Embryonal carcinoma cells 
ECM= Extracellular matrix 
EGF = Epidermal growth factor  
EMSCs= Ectomesenchymal stem cells 
EMT= Epithelial-mesenchymal transition 
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EPCs= Endothelial progenitor cells 
ESC= Embryonic stem cells 
FBS= Fetal Bovine Serum 
GDNF = Glial cell line derived neurotrophic factor  
GFAP= Glial fibrillary acidic protein  
GMP= Good manufacturing practice 
hDPSCs= Human DPSCs  
hESCs= Human ESCs 
HGF= Hepatocyte growth factor 
HNF-4α = Nuclear factor 4 α  
HSC= Hematopoietic stem cells  
IBMX= 3-isobutyl-1-methylxanthine  
ICM= Inner cell mass of the blastocyst  
IDO= Indoleamine 2,3-dioxygenase  
IL-xx= Interleukin-xx  
ITSx= Insulin-Transferrin- Selenium-x 
ISCT=International Society for Cellular Therapy  
LMX1a = LIM homoeo- box transcription factor 1 α 
MAP-2= Microtubule-associated protein-2 
MCAO= Middle cerebral artery occlusion  
mESCs= Mouse ESCs 
MI = Myocardial infarction  
MPTP = 1-methyl-4-phenyl-1,2,3,6-tetrahydropyri- dine- 
MSCs= Mesenchymal stem cells 
NC = Neural crest  
NCSCs= Neural crest stem cells 
NeuN= Neuronal nuclei protein  
NGF= Nerve growth factor  
NTRKxx= Neurotrophic tyrosine kinase 




NT-3= Neurotrophin 3 
NSC= Neural stem cell 
OSX= Osterix 
OGD= Oxygen-glucose deprivation  
PD= Parkinson´s disease 
Pdx1= Duodenal homeobox 1  
PDLSC= Periodontal ligament stem cells  
PitX= Paired-like homeodomain transcription factor 
PNS= Peripheral Nervous System 
POSS-PCL= Polyhedral oligosilsesquioxane–poly (ε-caprolactone)  
POSS-PCU= Polyhedral oligomeric silsesquioxane poly (carbonate-urea) urethane 
PPSCs= Primitive pluripotent stem cells  
PSCs= Pluripotent stem cells 
RA = Retinoic acid  
RGCs= Retinal ganglion cells  
RhoA= Ras homolog gene family member A  
RUNX2= Runt-related transcription factor 2  
SCAP= Stem cells from apical papilla  
SCI= Spinal cord injury 
SCNT= Somatic cell nuclear transplantation  
SFCs = Synovial fluid cells 
SGZ= Dentate gyrus Subgranular zone  
SHED= Stem cells from primary exfoliated deciduous teeth 
Shh= Sonic hedgehog  
SSEA= State-specific embryonic antigens 
STP= StemPro MSCTM 
SUR1= Sulfonyl- urea receptor1  
SVZ= Subventricular zone 
TERT= Telomerase reverse transcriptase   
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TGF-β3=Transforming growth factor-β III  
TH = Tyrosine hydroxylase  
TLR x= Toll-like receptor x 
TNF-α = Tumor necrosis factor-α  
TON= Traumatic optic neuropathy  
UCB-SCs = Umbilical cord blood stem cells  
UC-MSCs= Umbilical cord mesenchymal stem cells 
VMAT = Vesicular monoamine transporter  
VSELs = Very small embryonic-like stem cells  
WHO= World Health Organization 


























Stem cells are classically defined as cells with ability to self-renew, generating copies of 
themselves, and cells with capacity to differentiate under specific physiologic or experimental 
conditions to mature types of cells that constitute distinct organs and tissues (Potten and 
Loeffler, 1990). 
 
Stem cells were first described in 1950, when researchers isolated embryonal carcinoma 
cells (ECCs) from terathocarcinomas (Stevens and Little, 1954; Yu and Thomson, 2008). Few 
years after in 1964, Kleinsmith and Pierce discovered the ability of these cells to differentiate 
into all three germ layers. Given self-renewal and multi-lineage differentiation ability, the 
pluripotent stem cell (PSCs) concept was born, providing the first step to mouse and human 
embryonic stem cell (ESCs) description. All these discoveries along with propagation and study 
were only performed for in vitro models, until some researchers started searching in vivo models 
(Kahan and Ephrussi, 1970). In order to discover the in vivo similar ECCs model like, inner cell 
mass of the blastocyst (ICM) was analyzed (Martin, 1980). ICM showed to have even more 
differentiation potential than ECCs, increasing their use in in vitro models for development. 
This ICM is located in the blastocyst during embryonic development. After the division of the 
zygote when morula structure is achieved, outer layer cells differentiate to trophectoderm, 
which will derive in the placenta. ICM however, will create all cells of the adult body. Both 
human ESC (hESCs) and mouse ESC (mESCs) were obtained deriving ICM of human and 
mouse blastocyst, respectively. hESC are karyotypically common and remain the ability to 
differentiate into all three germ layers (Amit et al., 2000). 
 
Briefly, mesenchymal stem cells (MSCs) pluripotency was described taking in 
consideration the ability they showed to differentiate into mesenchymal derived cell lineages, 
such as; osteoblasts, chondrocytes, adipocytes and myoblast. Indeed, their ability to differentiate 
into one germ layer was defined like multipotency. This first MSCs were obtained culturing 
bone marrow cells and selecting thus that adhere to the plate (Chamberlain et al., 2007; 






















Figure 1. Schematic timeline showing the most important historical milestones in stem cell research (Oliveira et 
al., 2016). 
 
The differentiation potential of stem cells is defined by the developmental stage that they are in. 
Taking this fact in consideration stem cells could be divided in 3 groups: 
Totipotent: These cells can generate an individual, creating both a completely viable embryo 
and temporary support tissues (placenta and the umbilical cord). The totipotentiality of the cells 
lasts from just first fertilization to first cell division rounds, until blastomeric stage, 4 days after 
fertilization (Brook and Gardner, 1997). 
Pluripotent: During the differentiation undergo by embryonic cells during first 4 days of 
development, blastocyst is generated. ICM within the blastocyst are the ones defined as 
pluripotent stem cells. They are able to differentiate into cells from 3 germ layers, and hence to 
generate any tissue of the organism. However, the lost the ability to form extraembryonic 
tissues, such as placenta (Smith, 2001). 
Multipotent: The differentiation ability of multipotent stem cells is highly bounded compared 
with the two other stem cells described above. These cells can only differentiate into few cell 
types, and biological function is related with the reparation of their original tissue (Slack, 2000; 


















Figure 2. Differentiation potential of pluripotent stem cells and their origins (Oliveira et al., 2016). 
 
Within stem cells, there are to kind of cells; i) Embryonic stem cells, both totipotent and 
pluripotent cells. ii) Adults (after-birth) stem cells, both pluripotent and multipotent stem cells 
(figure 2).    
1.1Embryonic stem cells (ESCs) 
These pluripotent stem cells are located in the ICM of the blastocyst, and they remain the 
ability to differentiate to every adult tissue type. Since mouse ESCs were isolated for first in 
1981, the molecular mechanisms involved in the maintenance of self-renewing and pluripotency 
were studied due to their potential therapeutic applications (Evans and Kaufman, 1981) . 
Among these mechanisms, epigenetic chromatin changes, signal pathways and transcription 
factor effects were described as the responsible of pluripotency (Marks and Stunnenberg, 2014; 
Welling and Geijsen, 2013). Furthermore, transcription factors show an important role 
maintaining pluripotency both in vivo and in vitro (Dunn et al., 2014; Takashima et al., 2014), 
including Oct4 and Nanog, which seem indispensable in regulation (Boyer et al., 2005; Loh et 
al., 2006). 
1.2Adult stem cells 
All three stem cell types can be obtained from embryos; however, only two of them are 
achievable from adult individual. In vivo, pluri- and multi- potent stem cells are present in few 
specific tissues, even also can be generated using in vitro  techniques. 
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1.2.1Hematopoietic stem cells (HSCs) 
Hematopoietic stem cells (HSCs) are the precursors that gives raise to all red and white 
blood cells.  The generation of enteric hematopoietic system is given by these rare cells, which 
have a self-renewal ability and pluripotent capacity. Blood cell production occurs during the life 
of organism in the bone marrow (Ng and Alexander, 2017).  Taking in consideration that as 
over than million of blood cells must be replaced every day, and there are only thousands of 
stem cell population in adult organism throughout entire life, it is clear the importance of correct 
regulation to maintain homeostatic production and to face diseases and stress. HSC are located 
in bone marrow within adult mammals, and along with the hematopoietic microenvironment, 
they form the niche which is the modulator network to control broad aspects of hematopoiesis 
(Hoggatt et al., 2016). The most popular hypothesis says that primitive pluripotent stem cell 
(PPSCs), also known as very small embryonic-like stem cells (VSELs) CD45-, are at the top of 
the hierarchy of stem cell in the adult bone marrow. They can give raise to long-term 
repopulating HSC CD45+, short-term HSCs, MSCs and endothelial progenitor cells (EPCs) 
(Ratajczak, 2008). Adult long-term HSCs are located in a specific niche, closely associated with 
endosteum where they exist in a relative hypoxia condition (Morrison and Scadden, 2014; 
Nombela-Arrieta et al., 2013). These cells remain quiescent until cell cycle recruitment is 
activated by external signaling, such as; cytokine thrombopoietin, the presence of 
megakaryocytes or via interferon (Baldridge et al., 2010; Nakamura-Ishizu et al., 2015; 
Yoshihara et al., 2007). In addition, it is suggested that lineage specification of HSCs can be 
committed very early in the hematopoietic hierarchy in different HSCs progenitor cells. Thus, 
progenitors with self-renewing restricted ability may emerge directly from HSCs (Yamamoto et 
al., 2013). Therefore, there may coexist the idea of direct pathway from HSCs to specific mature 
cells and the idea of the progenitor mature cell pathway. Furthermore, new studies suggest the 
recruitment of long-lived progenitor populations maintains blood cell population in steady-state 
(Sun et al., 2014).  The most primitive myeloid progenitors are known as common myeloid 
progenitor (CMP) and common lymphoid progenitor (CLP) to  lymphoid progenitor(Iwasaki 
and Akashi, 2007). However, recent studies show that before to classical lymphoid/myeloid 
















Figure 3. Immunophenotypic markers of adult murine HSCs and ‘lineage-restricted’ HSC populations (Ng and 
Alexander, 2017).  
1.2.2Very small embryonic/epiblast-like stem cells (VSELs) 
It is a backup population that renews the pool of tissue committed stem cells defined as 
undifferentiated remain of stem cell population residing in adult tissue firstly described in 2006 
(Kucia et al., 2006). In addition, they are able to circulate throughout peripheral blood in stress 
situations and they express pluripotency markers Oct4, Nanog and SSEA, along with the 
capacity to differentiate into all three germ layers (Ratajczak et al., 2012).  
 
 1.2.3Neural stem cells (NSCs) 
The multipotent nature of neural stem cells (NSC), allow these to differentiate into 
central nervous system (CNS) neural cells. Contrary to what was thought years ago, NSC are 
not only found in embryo developing, but they are located also in adult brain. During 
embryogenesis, after neural tube formation by neuroepithelial cells, they proliferate 
continuously in the ventricular zone in order to generate CNS (Merkle and Alvarez-Buylla, 
2006). Furthermore, these cells are transforming to radial glial cells during embryogenesis, 
another NSC subtype with ability to differentiate in any neural cell type (Götz et al., 2015). 
Despite of at first it was thought that radial glial cells served only as a neuronal migration 
scaffold, several researches demonstrated high proliferation and the ability to generate neurons, 
therefore, they were defined as kind of stem cell (Hartfuss et al., 2001; Mo et al., 2007; Noctor 
et al., 2004) . While differentiated neural type are created, more radial glial cells are generated 
by asymmetric division to maintain stem cell population during brain development (Miyata et 
al., 2004). Later, these radial glial cells derive to multipotent NSCs in mammal postnatal brain 
(Merkle and Alvarez-Buylla, 2006; Merkle et al., 2004). The vertebrates with outstanding  adult 
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neurogenesis even contain radial glia within the adult brain (Adolf et al., 2006; Grandel et al., 
2006). Although vast neurogenesis in mammals is restricted to embryonic brain development, 
nowadays, it is accepted that there are two neurogenic cell-containing locations in human adult 
brain. New neural cell generation is observed in the dentate gyrus subgranular zone of the 
hippocampus (SGZ) (Gage et al., 1998) and in subventricular zone (SVZ) (Doetsch et al., 1999).  
SVZ shows a peculiar ranked NSCs. Radial glial cells disappear after birth, and only type B 
cells are remained, which will become in type C cells, identified by Mash1 expression. C cells 
at same time are the precursors of neuroblasts, also known as type A cells, and oligodendrocytes 
(Parras et al., 2004) (Figure 3).  Contrary to SVZ, NSCs of the SGZ in adult brain are named as 
radial astrocytes, and they share both astrocytic and stem features (Kriegstein and Alvarez-
Buylla, 2009). These cells function as precursors of the new neural cells in dentate gyrus 
(Garcia et al., 2004; Steiner et al., 2004) and new neurogenesis is related with learning and 
memory (Zhao et al., 2008). Radial astrocytes, also known as type I progenitors (Fukuda et al., 
2003) , show an vertical elongation crossing the granular cell layer as well as horizontal little 
process along SGZ. Furthermore, contrary to other astrocytes, radial astrocytes show both 
GFAP and nestin expression (Seri et al., 2004; Steiner et al., 2006). Radial astrocytes are not 
able to give raise to neurons, but they are deriving in processes lacking D type cells, also 
referred as type II progenitors (Seri et al., 2004). In spite of both radial astrocytes and D type 
cells express Sox2, it is suggested that only nonradial cells are direct progenitors of new 
neurons and glial cells (Suh et al., 2007). After division, D cells can undergo symmetric division 
before differentiate into D2 type cells, which show a prominent process and express stage 
dependent different neural markers, such as; doublecourtin, PSA-NCAM, neun, etc..(Kriegstein 
and Alvarez-Buylla, 2009) (Figure 4). Very few oligodendrocytes are obtained in vivo in SGZ 
compared with SVZ. Only Mash1 overexpression is essential to redirect the neuronal fate to 
oligodendrocytic in NSCs of SGZ (Jessberger et al., 2008). 
 
 




Figure 4. Neural stem cells origin and organization. (Kriegstein and Alvarez-Buylla, 2009) 
 
1.2.4Induced pluripotent stem cells (iPSCs) 
First time cell engineering was used to achieve genetically altered stem cells, the 
nucleus of a differentiated cell was transferred to an enucleated mouse oocyte by somatic cell 
nuclear transplantation technique (SCNT) (Wakayama et al., 1998). One year before, Wilmut et 
al published the successful cloning of Dolly sheep transferring the nucleus of differentiated cell 
to an enucleated unfertilized egg (Wilmut et al., 1997). However, there was an ethical issue 
related with human cells. In fact, this method could outcome in individual cloning that is a 
broadly discussed and controversial topic still nowadays. 
Taking in consideration ethical limitations showed by this technique, the aim became to 
develop reprogrammed pluripotent stem cells from differentiated somatic cells. Thus, the 
objective was the obtaining of cells with self-renewal and pluripotency properties similar to 
ESCs. iPSC concept was for first introduced by Takahashi and Yamanaka when they achieved 
the reprogramming of mouse fibroblasts. The reprogramming was given by retroviral 
transduction of Oct4, Sox2, Klf4 and c-Myc, also known as Yamanaka factors (Takahashi and 
Yamanaka, 2006).  It was the same group in charge of reprogramming human cells using the 
same method (Takahashi et al., 2007). In an effort to refine reprogramming procedure some 
changes were done in the methodology, among others; Nanog and Lin28 were used instead of 
Klf4 and c-Myc (Yu et al., 2007) and a combination of six factors to increase the efficiency in 
human fibroblast iPSCs (Liao et al., 2008). Several improvements were obtained such as; c-Myc 
seems to be dispensable in pluripotency induction (Wernig et al., 2008) and the combination of 
these factors with proteins, RNA and peptides to avoid viral infection related issues (Malik and 
Rao, 2013; O’Malley et al., 2009). 
Within adult stem cell type cells one of the most used cells are MSCs. Due to their ease 
of obtaining as well as the amount of them, these are the preferably selected adult stem cell to 
approach in vivo and in vitro tissue regeneration assays. 
 
1.2.5Mesenchymal stem cells (MSCs) 
Since Caplan popularized the term mesenchymal stem cell in 1990s, some researchers 
avoid to refer to cells with stem features in this way (Caplan, 1991). However, in 2000 in an 
International Society for Cellular Therapy (ISCT) workshop, the terminology was accepted and 
the acronym was coined (Horwitz and Keating, 2000). ISCT published a position statement to 
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settle the bases of the criteria to accurately describe and avoid misunderstood about MSCs. In 
agreement with this criteria MSC are primitive non-hematopoietic stromal cells able to 
differentiate into mesenchymal derived tissues with tissue regeneration function. They are 
located in bone, cartilage, muscle, ligament, tendon, adipose tissue (Chamberlain et al., 2007),  
in perivascular area (Crisan et al., 2008) and they could be also isolated from placenta, 
menstrual blood, umbilical cord and dental pulps in adult organism (Du et al., 2016; Ma et al., 
2014; Portmann-Lanz et al., 2006; Tirino et al., 2011).  
The most recognize immune-phenotype MSCs has been identified as positive for CD13, 
CD44, CD105, CD73 and CD90, while negative for hematopoietic markers CD34, CD45 and 
CD14.  
Following these features, Mesenchymal and Tissue Stem Cell Committee (MTSCC) of 
ISCT proposed minimal set to define MSC (Dominici et al., 2006): 
 1. MSCs have to be plastic-adherent when maintained under standard culture conditions. 
2. MSCs must have the ability for osteogenic, adipogenic, and chondrogenic differentiation. 
3. MSCs must express CD73, CD90, and CD105 (Table 1). 
 4. MSC must lack expression of the hematopoietic lineage markers c-kit, CD14, CD11b, CD34, 
CD45, CD19, CD79α,and human leukocyte antigen (HLA)-DR. 
It is important to highlight the immune-phenotype difference depending on MSC tissue 
origin, as it is describe in table 1.  
The highlights of MSCs are the self-renewal ability and pluripotent differentiation 
capacity. MSCs have the ability to differentiate into mesenchymal cells, such as adipocytes, 
fibroblasts, osteocytes and chondrocytes. In addition, MSCs have the capacity to become in 
other non-mesenchymal lineage specific cell types, undergoing the process called cross-
differentiation (Hass et al., 2011; Ullah et al., 2015).  
Apart from pluripotency, also their clinical application could be very interesting due to 
their homeostasis maintenance as well as their contribution in processes as aging, tissue damage 









Table1. BM-MSCs, AT-MSCs and UC-MSCs immune-phenotype. 
 
1.2.5.1Bone marrow mesenchymal stem cells (BM-MSCs) 
Bone marrow not only contains hematopoietic stem cells, but also non-hematopoietic 
stem cells, such as bone marrow mesenchymal stem cells (BM-MSCs) and endothelial 
progenitor cells (Anjos-Afonso and Bonnet, 2007). BM-MSCs showed natural immune 
function, inhibition of local inflammatory responses and sepsis (McLean et al., 2011; Wang et 
al., 2015; Yang et al., 2013). It is known that CD44, CD73, CD90, CD105 and CD166 are 
positively marked, while CD14, CD34, CD45 are negatively expressed in these cells (table 1) 
(De Ugarte et al., 2003; Pittenger et al., 1999). 
Although their differentiation ability is limited in comparison with ESC, BM-MSCs 
have showed an incredible differentiation capacity in vitro. Indeed, they are able to differentiate 
into all three lineages cell type; ectoderm, mesoderm and endoderm   (Ullah et al., 2015; Zhang 





 BM-MSCs AT-MSCs UC-MSCs 
Positive CD13, CD44, CD73, 
CD90, CD105, 
CD166, STRO-1 
CD9, CD13, CD29, 
CD44, CD54, CD73, 
CD90, CD105, 
CD106, CD146, 
CD166, HLA I, 
STRO-1 
CD11b, 
CD29, CD44, CD90, 
CD73, CD105 
 
Negative CD14, CD34, CD45 CD11b, CD14, CD19, 
CD31, CD34, CD45, 
CD79a, CD133, 
CD144, HLA-DR 
CD31 CD34, CD45, 
CD117,HLA-DR  









Figure. 5. Mesenchymal stem cell sources. (Guasti et al., 2018) 
 
Ectoderm: Under well-known neural induction medium consisting of growth factor cocktails, 
some groups have identified BM-MSC ectodermal lineages cell type differentiation despite of 
mesenchymal being of BM-MSCs. Rat and human BM-MSC were differentiated into neuronal 
cells in 2000 by containing simple induction media consisting in DMEM/2% dimethylsulfoxide 
(DMSO)/200 µM butylated hydroxyanisole (BHA) (Woodbury et al., 2000). Several groups 
follow this way in order to achieve more effective differentiation protocol. Both mouse and rat 
BM-MSCs were differentiated in neural cells by bFGF, FGF-8 and BDNF cocktails for 7 days, 
sequentially (Jiang et al., 2002). Even specific neuronal cell types are achieved modifying 
primary culture conditions. Thus, human BM-MSCs reprogramming with LMX1a, which is 
described as important piece in dopaminergic differentiation both in vivo and in vitro, resulted 
in dopaminergic differentiation (Barzilay et al., 2009; Wilkins et al., 2009). Regarding to 
dopaminergic induction, new investigation show the importance of cell passage number, the 
more passages have a cell, less dopaminergic differentiation and lower spiking and bursting 
frequencies shows it (Shall et al., 2018). As a counterpart of dopaminergic differentiation, also 
cholinergic neurons were obtained following a 1 mM b-mercaptoethanol (BME) and nerve 
growth factor (NGF) (100 ng/mL) consisting of 2 step induction protocol (Naghdi et al., 2009).  
Mesoderm: Taking in consideration the mesenchymal origin of BM-MSCs, it is not a surprise 
the ability of BM-MSCs to derive in mesodermal lineages cells. Several projects have 
confirmed the in vitro differentiation into adipocytes, osteocytes and chondrocytes using several 
differentiation cocktails. First stablished chondrocyte differentiation protocol was given for 
BM-MSCs (Mackay et al., 1998). After that, the differentiation was confirmed by some other 
research, while differentiation was analyzed by measuring oil droplet generation, mineralization 
and type collagen II secretion respectively (Gronthos et al., 1994; Muruganandan et al., 2009; 
Ranera et al., 2013; Wagner et al., 2005; Zhang et al., 2011). Combining the in vitro 




differentiation capacity and new gene recombination technologies, more healer BM-MSCs have 
been obtained in order to use them in regenerative therapies. In this case BMP-7 overexpression 
in BM-MSCs lead to a better fracture healing ratio than wild type BM-MSCs  (Yan et al., 2018). 
Apart from these three cell types, also cardiomyocytes were derived from BM-MSCs. 9 years 
after the first attempt in rat BM-MSCs using 5-azacytidine, where multinucleated myotubes 
were obtained (Wakitani et al., 1995), the same protocol was used in human BM-MSCs to 
achieve myocyte-related genes, β-myocin heavy chain, α-cardiac actin, desmin and calcium-
potassium-induced calcium channels expressing differentiated cells (Xu et al., 2004). Moreover, 
the differentiation into endothelial cells have been seen in BM-MSCs, where the down-
regulation of IncRNA MEG3 seems to be a key as well as the effect of biphasic calcium 
phosphate ceramic (Chen et al., 2018; Sun et al., 2018; Urbich and Dimmeler, 2004). 
Endoderm: Although hepatocytes were thought to derived only from endodermal progenitor 
cells, MSCs demonstrated an unexpected hepatogenic differentiation ability. Exposing BM-
MSC to specific 2 step protocol consisting in; a week of a differentiation step where basal 
medium was supplemented with bFGF, EGF and nicotinamide, following by maturation step 
where medium was supplemented with oncostatin M, dexamethasone and ITS+ (insulin, 
transferrin, selenium) premix, they are able to become into hepatic cells. After the treatment 
they expressed liver specific transcription marker albumin, α-fetoprotein, nuclear factor 4 α 
(HNF-4α) as well as liver cells characteristic functions such as; albumin production, glycogen 
storage, urea secretion, uptake of low-density lipoprotein, and phenobarbital-inducible 
cytochrome P450 production  (Lee et al., 2004; Stock et al., 2014). Even non-human BM-MSCs 
hepatocytic differentiation is demonstrated in different species; from mouse to Tibetan mastiff 
(Xu et al., 2017b; Zhang et al., 2018a). Furthermore, the use of coating substrates to improve 
the proliferation, hepatic differentiation and hepatocyte-specific functions during the culture 
along with to ease the engraftment in vivo as scaffolding, has become an aim in last years. 
Coating plates with both liver extracellular matrix (ECM) and matrigel showed a significant 
improvement of differentiation and viability in BM-MSCs (Wang et al., 2018). 
Like happens with hepatocytes, pancreocyte differentiation ability of BM-MSCs was 
unexpected. However, there are some elegant works where BM-MSCs are successfully 
differentiated to insulin producing β-cells both in vitro and in vivo. The ability to differentiate 
these cells in vitro by specific inductive media, is going beyond than only morphological change 
but they are able to correct the streptozotocin-induced hyperglycemic condition (Gabr et al., 
2013, 2014; Tang et al., 2012). It is also demonstrated the capacity of these cells to differentiate 
into endocrine pancreatic lineage cells in vivo in the presence of paracrine factors, extracellular 
vesicle-mimetic nanovesicles, etc..(Bhonde et al., 2014; Oh et al., 2015; Phadnis et al., 2011). 




 1.2.5.2Adipose tissue mesenchymal stem cells (AT-MSCs) 
 The adipose tissue has been classified as energy storing tissue composed by different 
cells. Within adipose tissue could be find adipocytes, endothelial cells, hematopoietic cells, 
fibroblasts and adipose tissue mesenchymal stem cells (AT-MSCs), all of them irrigated by an 
intermingling vasculature (Eto et al., 2009). Although AT-MSCs are similar to BM-MSCs in 
morphology and phenotype, there are important differences in cell harvest and cell yield 
(Markarian et al., 2014). In addition, it is demonstrated that transcriptome is different depending 
on MSC tissue origin. Thus, proliferation related genes are upregulated in AT-MSCs compared 
with BM-MSCs, which match with the fact of AT-MSC multiplied faster to up to 20 passages 
compared to BM-MSCs (Wagner et al., 2005) . AT-MSCs can be isolated from the patient 
himself with minimal donor morbidity, being useful to “autologous” cellular therapies. These 
cells are present in subcutaneous adipose tissue in both inguinal and abdominal areas (Hu et al., 
2014; Maharlooei et al., 2011; Zografou et al., 2013). The AT-MSCs denomination requires 
specific immune-phenotype and differentiation capacity criteria. Commonly described as 
fibroblastic-like large nucleus containing cells, their immune-phenotype have been defined as 
positive to CD9, CD13, CD29, CD44, CD54, CD73 (SH3), CD90, CD105 (SH2), CD106, 
CD146, CD166, HLA I, STRO-1 and negative to CD11b, CD14, CD19, CD31, CD34, CD45, 
CD79a, CD133, CD144, HLA-DR (table 1) (Chen et al., 2013; Schäffler and Büchler, 2007; 
Zuk et al., 2002).  
 Like happens with BM-MSCs, AT-MSCs are able to differentiate into all three lineage 
cells (ectodermic, mesodermic and endodermic) apart from expected mesenchymal lineage cells 
(Gadelkarim et al., 2018; Schäffler and Büchler, 2007; Ullah et al., 2015). 
Ectoderm:  Neural differentiation of AT-MSCs was first reported by Safford, who confirmed 
neural differentiation by nestin and neuronal nuclei protein (NeuN) expression (Safford et al., 
2002). Years later, several groups followed differentiating neural cells from AT-MSCs.  
Different inductive protocols were used for this aim, among others; simple neurobasal medium 
(Dave et al., 2018), neural induction media containing FGF2, EGF, BMP-9, retinoic acid and 
heparin to obtain cholinergic and dopaminergic neurons (Marei et al., 2018), olfactory 
ensheathing cells (OECs) or Schwann cells (SCs) conditioned medium (CM) (Lo Furno et al., 
2018), and even  one group achieve NSCs combining neurobasal media with EGF and bFGF 
(Petersen et al., 2018). In addition, new approach of neuro-differentiation based in the most 
common neuro-inductive material, graphene oxide, and in the one of the most important 
neuronal migration, proliferation and function regulators, calcium, also have demonstrated their 




important role in the differentiation of AT-MSC to neuronal lineages (Feng et al., 2018; 
Goudarzi et al., 2018). 
Mesoderm: Transcriptional and molecular events responsible of lineage-specific mesodermal 
differentiation into osteocytes (Lian et al., 2004; Zhao et al., 2018), chondrocytes (Otto and 
Rao, 2004), adipocytes (Rosen, 2002) and myocytes (Brand-Saberi, 2005) are already studied 
and well-known. AT-MSCs derived adipocytes develop both white and brown adipocyte mature 
features, such as; lipolytic capacity under catecholamine stimulation, anti-lipolytic activity 
mediated by α2-adrenoceptors, and the secretion of typical adipokines, such as adiponectin and 
leptin. (Dicker et al., 2005; Kilroy et al., 2018; Rashnonejad et al., 2018). Could be interesting 
the use of preadipocytes more than the use of mature adipocytes, thanks to their smaller size 
mediated quicker revascularization ability, in vivo differentiation effectiveness and low oxygen 
consumption (Heimburg et al., 2005) . New sources of osteogenic progenitor cells are needed 
since bone tissue engineering requires large amounts of osteocytes. It is described the similar 
ability for osteogenic differentiation showed by BM-MSCs and AT-MSCs, even if the age of 
donor is increase (Shi et al., 2005). However, it is also published that  AT-MSCs have inferior 
potential for osteogenesis and inferior ability in the treatment of partial growth arrest in murine 
model  than MSCs have (Hui et al., 2005; Im et al., 2005). Both human and mouse AT-MSCs 
can acquire typical osteogenic differentiation hallmarks, such as mineralized extracellular 
matrix production, osteoblast-associated proteins osteocalcin and alkaline phosphatase 
expression, responsiveness to fluid shear stress and the expression of mechanosensitive genes 
(osteopontin, collagen type Iα1, and COX-2 ) after mechanical loading (Ardeshirylajimi et al., 
2014; Jia et al., 2018; Knippenberg et al., 2005). Several signaling pathways have been 
identified as regulators of osteodifferentiation including TGFB/BMP, Wnt/B-Catenin, Notch, 
Fibroblast growth factor and Hedgehog. BMP is in particular an important key of osteogenesis, 
and the most important elements are BMP2 and 7. Treating AT-MSCs with recombinant BMP2 
and BMP7 stimulates osteogenic and adipogenic differentiation, respectively (Dragoo et al., 
2003; Knippenberg et al., 2006). Thus, genetically modified AT-MSCs overexpressing BMP2 
were successfully used to heal femoral defects (Peterson et al., 2005). BMP can activate 
differentiation either activating BMPR I and II receptors or activating both Runt-Related Protein 
2 (Runx-2) and osterix (OSX), which are considered the master regulation genes for bone 
formation (Heldin et al., 1997; Lian et al., 2006). Furthermore, other elements, such as Tbx3 
(Lee et al., 2007b) and FOXO1 (Zhao et al., 2018) have showed an important role in osteogenic 
differentiation of AT-MSCs. Apart from specific differentiation factors, extracellular matrix 
substitutes and three-dimensional environment scaffolds are critical for a successful 
differentiation. Hence, chitosan particle-agglomerated scaffolds, fibrin scaffolds, α-tricalcium 
phosphate scaffolds as well as gum tragacanth hydrogel have been reported as suitable 
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scaffoldings (B Malafaya et al., 2005; Haeri et al., 2016; Hattori et al., 2006).  There are many 
protocols to obtain chondrogenic differentiation; from the simplest one in which there are not 
factor added (Wagner et al., 2005), to the standard protocol for chondrogenesis combines 
DMEM with ITS+, linoleic acid, selenious acid, pyruvate, ascorbate 2-phosphate, 
dexamethasone and transforming growth factor-β III (TGF-βIII). It is known that pre-induction 
stage of chondrogenic differentiation carry MSCs express type I and II collagens. The 
expression of chondrogenic genes and adhesion molecules depends on the presence of TGF-β 
family (TGF-β1, TGF-β2and TGF-β3) soluble factors. The maturation of chondrocyte is 
achieved once they express Sox9, L-Sox5 and Sox6  chondrogenic transcription factors 
(Chimal-Monroy and Díaz de León, 1999; Ikeda et al., 2004). Furthermore, apart from TGF-β1, 
which in humans interacts with Wnt/β- catenin pathways to inhibit osteogenic differentiation to 
support chondrogenesis (Zhou, 2011) , other growth factors such as, insulin like growth factor-I 
(IGF-I) and BMP-2 are known to induce the chondrogenic differentiation of AT-MSCs (An et 
al., 2010; Wei et al., 2006). Commonly used polyhedral oligomeric silsesquioxane poly 
(carbonate-urea) urethane (POSS-PCU) and polyhedral oligosilsesquioxane–poly (ε-
caprolactone) (POSS-PCL) cyto-compatible novel bioscaffolds, are effective in chondrogenic 
differentiation (Griffin et al., 2017; New et al., 2017). 
Many investigations support AT-MSCs differentiation toward cardiomyocytes. When 
AT-MSC are cultured under specific conditions, they are able to achieve cardiomyocytes-like 
phenotype with pacemaker activity and specific cardiac marker expression (Planat-Bénard et al., 
2004). Moreover, other researchers have showed how the engraftment of AT-MSCs in murine 
myocardial injury models they are able to differentiate in cardiomyocytes, promote angiogenesis 
and even either  improve or heal injured areas (Miyahara et al., 2006; Strem et al., 2005). Even 
these data were obtained from murine models some new works supported also differentiation 
into functional contractile cardiomyocytes from human origin (Choi et al., 2010) and 
emphasized in the important role of ascorbic acid in generation of AT-MSCs derived 
cardiomyocytes through MEK/ERK signaling pathway (Liu et al., 2018b). 
Unexpectedly, as happens with BM-MSCs, AT-MSCs have demonstrated the ability to 
differentiate into endothelial cells, which show proangiogenic potential, post-ischemic 
neovascularization and vessel-like structure formation as well as secretion of endothelial cell-
related elements, such as VEGF, hepatocyte growth factor (HGF), placental growth factor, 
FGF-2, TGF-β , and angiopoietin-1 (Bekhite et al., 2014; Cao et al., 2005; Rehman et al., 2004). 
Endoderm: First human AT-MSCs were differentiated into pancreatic endocrine phenotype 
using the differentiation factors activin-A, exendin-4, HGF, and pentagastrin. These cells were 
able to express endocrine pancreatic hormones insulin, glucagon and somatostatin along with 




pancreatic developmental transcription factors Pax-6, Ipf-1, and Ngn-3 (Timper et al., 2006).  
Despite new investigations shedded light to the AT-MSCs differentiation ability comparing with 
BM-MSC, it was not clear what was the process underwent by these cells (Gabr et al., 2014). 
Several groups manipulate AT-MSCs genetically, with the purpose to provide new strategies to 
understand pancreatic endocrine differentiation mechanism. Thus, has been demonstrated how 
the combined effect of Pdx1 and Shh overexpression in rat AT-MSCs insulin producing cells, 
can increase insulin production along with the expression of MafA, Nkx2.2, Nkx6.1, Ngn3, 
insulin, and Isl1. At the same time, these cells exhibited the ability to normalize blood glucose 
values in diabetic rats (Hashemi Tabar et al., 2018). In the same way, another investigation 
point to the activation of Wnt pathway during differentiation (Wang et al., 2017b). The use of 
3D scaffolding will probably be the future in autologous diabetes mellitus I cell therapies. 
Combining both 3D scaffolding PVA and platelet-rich plasma (PRP) the differentiation protocol 
of AT-MSCs derived insulin producing cells have been optimized (Enderami et al., 2018). 
AT-MSCs cultured with HGF, oncostatin M (OSM), and dimethyl sulfoxide derived in 
hepatocyte-like phenotype expressing albumin and α-fetoprotein with the ability to avoid low-
density lipoprotein increase and produce urea (Seo et al., 2005). Murine models demonstrated 
the viability of AT-MSCs hepatocytic differentiation assays resulting in functional periportal 
and pericentral hepatocyte. They even had the ability to restore the liver function after carbon 
tetrachloride (CCl4)-induced acute fulminant liver failure (Winkler et al., 2015; Xu et al., 
2015a). As model counterpart, there are several works, where totally functional and histo-
compatible hepatocyte-like cells are obtained from human AT-MSCs both in vitro and in vivo 
using different induction protocols (Aurich et al., 2009; Lee et al., 2012; Wang et al., 2014). 
 
1.2.5.3Umbilical cord stem cells (UC-MSCs) 
The development of human umbilical cord starts in the 5th week of embryogenesis 
(Ellis, 1989). In addition to common adult tissues (adipose tissue, bone marrow), MSCs can be 
obtained from birth associated tissues including placenta, amnion and umbilical cord (figure 5). 
Umbilical cord stem cells (UC-MSCs) are a high accessible and ethically acceptable novel cell 
source. These cells can be non-invasively obtained after birth, and they seem to be more 
primitive than the others MSCs located in adult tissues, ergo, they have intermediate features 
between adult and embryonic stem cells (El Omar et al., 2014). Taking in consideration last 
investigations about UC-MSCs, their immune-phenotype has been standardized as positive for 
CD29, CD10, CD13, CD58, CD59, CD61, CD44, CD90, CD73, CD106, CD166, CD325, 
CD56, CD51 and CD49(b-e) and negative for CD31, CD3, CD11b, CD14, CD19, CD31, CD33, 
CD34, CD38, CD40, CD49a,CD34, CD45, CD117, CD133, CD86, CD80, CD71, CD56, CD53, 
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CD50 and HLA-DR. Some data are contradictory depending on the report; CD54, CD105, 
CD106, CD117, CD144 and CD146. The contradiction of CD105 is specially unexpected due to 
its importance in mesenchymal stem cell identification. However, in most studies CD105 is 
expressed, only few studies have shown that either it is not expressed or the expression is 
decreasing along with the passage is increasing  (table 1) (Batsali et al., 2013; Can and 
Karahuseyinoglu, 2007; El Omar et al., 2014; Seo et al., 2009). The investigations carried out 
after their description in 1656 have demonstrated the big amount of these cells, the high 
proliferation capacity and the safety to use them in cell therapies (Fong et al., 2011; Friedman et 
al., 2007). After animal disease model experiments support the use of human UC-MSCs in 
clinical trials some clear conclusions are taken. UC-MSCs used in cardiac, skin, 
musculoskeletal, ophthalmologic, pulmonary, endocrine, liver, hematologic and neurologic 
diseases showed anti-apoptotic, immunomodulatory, anti-fibrotic and angiogenic properties 
along to stem cell related benefits. Furthermore, they did not show infusion-related toxicity, 
which make these cells attractive tool for cell therapies. However, all works mentioned the need 
to refining nomenclature in researches to discern between different cell types of umbilical cord  
(Arutyunyan et al., 2016; Can et al., 2017).  
Hence, it is important to highlight that UC-MSCs can be isolated from different parts of 
umbilical cord, such as Wharton´s jelly, cord lining and umbilical cord blood. Both cord lining 
and umbilical cord blood contains more than one cell type, only few of them are MSCs (Maria 
et al., 2010).  
1.2.5.3.1Wharton´s jelly 
Umbilical cord tissue used to be medical waste until 1991, when fibroblast-like cells 
where discovered in this tissue (McElreavey et al., 1991). Years later, these cells were taken as 
MSCs due to their immune-phenotype and their differentiation ability (Wang et al., 2004). Two 
arteries and one vein, all of them surrounded by mucoid connective tissue known as Wharton´s 
jelly, compose the umbilical cord (figure 6). This gelatinous connective tissue is protecting 
blood vessels from clumping providing them flexibility, and it is also covered by an amnion 
derived epithelium, which is named cord lining. It is described that Wharton´s jelly is composed 
by glycosaminoglycans, specially hyaluronic acid and chondroitin sulfate. In absence of elastic 
fibers, collagen fibers are the main fibrillary component. Regarding to cell-composition, it is fill 
by mesenchyme derived cells, such as fibroblasts, myofibroblasts, smooth muscle cells and 
mesenchymal stem cells (Arutyunyan et al., 2016). MSCs can be isolated from perivascular, 
intervascular and subamnion zones within Wharton’s jelly (Maria et al., 2010). 
 














Figure 6. UC-MSC. Modified from (Ding et al., 2015)  
 
1.2.5.3.2Cord lining 
Two kind of cells can be isolated from this area, cord lining mesenchymal cells 
(CLMCs) and cord lining epithelial cells (CLECs). CLMCs are achieved from the subamnion 
region dissecting out Wharton´s jelly and have been used for burn and diabetic wound healing. 
On the other hand, CLECs have been used both to skin cosmetic trials, ocular disorders, insulin 
dependent diabetes, liver failure, wound regeneration and for treating persistent corneal 
epithelial defects(Lim and Phan, 2014; Saleh and Reza, 2017). 
 
1.2.5.3.3Umbilical cord blood stem cells (UCB-SCs) 
Umbilical cord blood stem cells (UCB-SCs)  are first isolated fetal stem cells. UCB-SCs 
were declared source of hematopoietic stem and progenitor cell in 1974 (Ali and Al-Mulla, 
2012; Knudtzon, 1974). Nowadays, umbilical cord blood containing different stem cell 












Figure 7. UCB-SCs types (Ali and Al-Mulla, 2012). 
Hematopoietic stem cells: As it is described above (HSCs, 1.2.1 chapter), all blood cells are 
created from these multipotent stem cells. HSCs located in umbilical cord blood contain 
different commitment stages of HSCs. In comparison with any other MSCs, their main 
characteristic is the expression of hematopoietic origin surface markers; CD133, CD34 and 
CD45 (McGuckin et al., 2003). 
Mesenchymal stem cells: These cells are the mesenchymal part of stem cellular components in 
umbilical cord blood, also known as umbilical cord mesenchymal stem cells (UC-MSCs). As 
the others MSCs, UC-MSCs showed the ability to differentiate into mesodermal lineage cells as 
well as into non-mesodermal lineages (da Silva Meirelles et al., 2006). They have a high 
proliferation capacity (Bieback et al., 2004). 
Multipotent non-hematopoietic stem cells: Their presence is minimum and are negative to 
CD45, hematopoietic marker (McGuckin et al., 2005; Zhao et al., 2006). They have displayed 
embryonic pluripotential related OCT4, SOX2 and NANOG markers, as well as human 
embryonic stem cell specific surface markers state-specific embryonic antigens, SSEA-3 and 
SSEA-4, among others (Inamdar et al., 2009). These cells have shown the ability to differentiate 
into three germ layers cell types. Multipotent non-hematopoietic stem cells have been  
differentiate into ectodermal lineage neural cells (Zangiacomi et al., 2008) , hepatic and 
pancreatic endodermic lineage cells (Denner et al., 2007; McGuckin et al., 2005), and 
endothelial cells from mesodermal lineage(Ma et al., 2006). The differentiation potential and 
accessibility, become UC-MSCs in a promising source of stem cell source for research and even 
to cell therapy applications (Ali and Al-Mulla, 2012). 
 
Ectoderm: UC-MSCs have the ability to differentiate into neurons, astrocytes and other glial 
cells, even it is demonstrated that they can rescue a stroke in a rat model increasing neurotrophic 
factors and β1-integrin (Ding et al., 2007; Liu et al., 2010).  Differentiation protocols have been 
optimized to achieve specific neuronal cells; expressing dopaminergic specific markers, such as 
tyrosine hydroxylase (TH), dopamine, cyclic AMP regulated phosphoprotein (DARPP) 32, 
paired-like homeodomain transcription factor (PitX) 3 and vesicular monoamine transporter 
(VMAT) 2 with 65% of differentiation efficiency (Datta et al., 2011; Fong et al., 2011; Mitchell 
et al., 2003). Also oligodendrocytes and astrocyte differentiation were achieved (Leite et al., 
2014; Mitchell et al., 2003).  




There also few works that differentiate UCB-MSCs into neural lineages. The 
combination of telomerase reverse transcriptase (TERT) and brain derived neurotrophic factor 
(BDNF) improved UCB-MSC viability, proliferation and neural differentiation (Zhao et al., 
2014). In other case, Cardiotrophin-1 (CT1) stimulates differentiation of UCB-MSCs and their 
survival through PI3/AKT pathway (Peng et al., 2017).  
Mesoderm: In spite of UC-MSCs derived adipocytes have shown to create small lipid vacuoles, 
they also have the capacity to maintain multipotency for longer periods compared with BM-
MSCs (Fong et al., 2012; Mennan et al., 2013). Some investigations focus their efforts in 
elucidate which mechanism interfere in adipogenic differentiation. BMP-9 show to be a key in 
adipogenic, chondrogenic and osteogenic differentiation (Shu et al., 2018). Like happens with 
other MSCs, UC-MSCs can be cultured in different scaffoldings, however, never substrate 
stiffness was taken as important element in differentiation. Different lineage commitment can be 
undergo depending on the rigidity of the material. UC-MSCs show to tended to differentiate 
into adipocytes in soft matrix, however, cells cultured in high-stiffness undergo osteoblastic 
differentiation (Xu et al., 2017a).  
Osteogenic differentiation was less effective in UC-MSCs than other MSCs (Ishige et 
al., 2009), however MSCs from other part of the umbilical cord showed higher osteogenic 
potential. Wharton jelly´s MSCs had higher osteogenic potential than the other UC-MSCs 
(Mennan et al., 2013).  
Regardless of the place of the umbilical cord they were isolated from, all the cells 
revealed the same chondrogenic potential, increasing in 3 the potential showed by BM-MSCs 
(Mennan et al., 2013). 
Endoderm: Human UC-MSCs are able to express hepatic markers and to differentiate both in 
vivo and in vitro. When UC-MSCs were transplanted into chemically injured liver rat model 
they differentiated into hepatocytes and even they successfully engrafted into injured liver 
(Campard et al., 2008; Lin et al., 2010). 
Regarding to insulin producing cells, effectively differentiated human UC-MSCs in 
vitro could recovery normal glycemic values after portal vein injection both in rats and mice 
(Tsai et al., 2012; Wang et al., 2011).   
 
1.2.5.4Dental pulp stem cells (DPSCs)                                                                                                                                                                   
Like happens with other tissues, also oral cavity contains MSCs population in adult 
organisms (Huang et al., 2009). Gronthos et al. described in 2000 the existence of unique stem 
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cell population very similar to BM-MSCs derived from dental pulp tissue (Gronthos et al., 
2000). Due to their ability to self-renewal and capacity to differentiate into neurogenic and 
mesenchymal lineage cell, they were named as dental pulp stem cells (DPSCs) (Gronthos et al., 
2002). The tooth structure consists of an outer enamel layer (created by ameloblasts), following 
by dentin layer (created by odontoblasts), which surrounds a dental pulp located into tooth 
cavity (Shi and Gronthos, 2003). Dental pulp is a soft connective tissue containing nerves, blood 
vessels, mesenchymal tissues and mesenchymal cells (mesenchymal stem cells, fibroblasts, 
immune cells). This has an important role in primary and secondary tooth development and 
protection in front of insults and injuries, such as caries. DPSCs have shown high-proliferative 
capacity and more important, they are accessible without invasive surgical procedures (Gardin 
et al., 2016) (figure 8)(figure 9, red). Nowadays, there are not standard immune-phenotype to 
define DPSCs. However, it is well defined the expression of three surface stem mesenchymal 
markers CD73, CD90, CD105 required by ISCT to consider DPSCs mesenchymal stem cells. In 
addition, several works have compiled the expression of CD27, CD29, CD44, CD146, CD166, 
CD271 and STRO-1. In the contrary, DPSCs do not express CD34, CD45 ( hematopoietic 
markers), CD14 (monocyte or macrophage marker), CD19 (B cell marker) and HLA-DR 
(human leukocyte antigen) surface molecules (Anitua et al., 2018; Gronthos et al., 2002; 
Kawashima, 2012). Moreover, DPSCs express Oct-4, Nanog and Sox2 stem pluripotential 
markers as well as neural stem cell markers (Nestin, Vimentin) and mesenchymal (Vimentin, 
Collagen I) markers. In addition, DPSCs express other cranial neural crest cell-related neural 
markers such as glial fibrillary acidic protein (GFAP), β-III tubulin and microtubule-associated 









Figure 8. Tooth longitudinal section (Gardin et al., 2016). 
 





1.2.5.4.1Neural crest origin and ectomesenchymal being 
The neural crest (NC) is a transient structure composite by a population of a pluripotent  
cells located at the lateral edge of neural tube in vertebrate embryos. Neural crest stem cells 
(NCSCs) have the capacity to migrate throughout the body to generate several cells type 
achieving diverse array of tissues, such as skin melanocytes, endocrine cells in the adrenal and 
thyroid glands, peripheral nervous system (PNS) and most craniofacial structures such as bones, 
tongue, craniofacial nerves and muscles (Shyamala et al., 2015; Vega-Lopez et al., 2017). In 
fact, craniofacial structures are composed by special NCSCs. During neural tube creation, the 
edges of neuroectoderm edges join after neural fold. Once, tubular shape is achieved neural 
crest stem cells undergo epithelial-mesenchymal transition (EMT), becoming ectomesenchymal 
stem cells (EMSCs). So, they are already EMSCs, when NCSCs migrate to create craniofacial 
structures, which create craniofacial connective tissues including dental pulp and periodontal 
ligament during embryonic development (figure 9) (Ibarretxe et al., 2012). DPSCs and the 
others dental stem cells described above, have been constituted as NCSCs source in adult tissue 









Figure 9. Neural crest cells origin  (Ibarretxe et al., 2012). 
 
1.2.5.4.2Other dental stem cells 
Although DPSCs are the most used cells for research purposes, it must be remarked that 
not only DPSCs have been identified among dental stem cells. There exist dental follicle stem 
cells (DFSCs) and stem cells from apical papilla (SCAP) in developing teeth tissues and there 
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are periodontal ligament stem cells (PDLSCs) and stem cells from primary exfoliated deciduous 
teeth (SHED) in adult teeth (Ibarretxe et al., 2012; Sharpe, 2016) (figure 9).   
DFSCs: These cells are isolated from the ectomesenchymal embryonic tissue that cover tooth 
germ in tooth development. In adults, DFSCs can be found in pre-erupting wisdom teeth follicle 
(figure 10, purple) (Morsczeck et al., 2005). Despite of the specific ability of DFSCs to 
differentiate into periodontal tissue related cells, they are also able to differentiate into other cell 
lineages in vitro (Honda et al., 2010; Morsczeck et al., 2017). 
SCAP: This high proliferative ectomesenchymal stem cell (EMSC) population is located 
surrounding apices of root sheath of developing teeth (figure 10, yellow).  Although these cells 
are currently present in development of teeth morphogenesis, SCAP is also present in pre-
erupting wisdom teeth in adults (Bakopoulou et al., 2011). SCAP have shown differentiation 
capability, not only to common mesenchymal lineage cells, but also show neurogenic and 
angiogenic potential in specific conditions (Nada and El Backly, 2018). 
PDLSCs: In 2004, Seo et al. obtain MSCs with similar proliferation, clonogenic differentiation 
capability and basal expression of pluripotential markers to adult DPSCs from perivascular 
space of periosteum, these cells were named periodontal ligament stem cells (PDLSCs)(Liu et 
al., 2018a; Seo et al., 2004; Trubiani et al., 2010) (figure 10, blue).  
SHED: As happens with DPSCs, also primary human exfoliated deciduous teeth are an EMSC 
population. SHED high proliferative rate, basal neural marker expression, expression of 
pluripotency markers and even the capacity to survive and integrate in host brain tissue (Kerkis 
et al., 2006; Miura et al., 2003)(figure 10, red). In addition, SHED have shown a remarkable 
differentiation ability to mesenchymal lineages (Bento et al., 2013; Sakai et al., 2010) as well as 
neurogenic lineages (Brar and Toor, 2012; Zhang et al., 2016b). Taking in consideration such 
properties population could be used as EMSCs source, however, their availability is limited in 




adult human being and their collected material amount is reduced due to root resorption during 
exfoliation.  
Figure 10. Dental stem cell types. Modified from (Sharpe, 2016).   
 
In order to elucidate if DPSCs are actually a good source of stem cell to use in 
regenerative cell therapies these cells have been compared with other studied stem cell sources. 
In one of the first works where DPSCs were compared with BM-MSCs, similar differentiation 
capabilities and neural and glial specific marker expression were discovered in both cell types. 
However, they showed DPSCs were more active and developed metabolically than BM-MSCs, 
concluding DPSCs remain better neural and epithelial stem cell features (Karaöz et al., 2011). 
Later, DPSCs were compared with other accessible MSCs sources. In this work the 
morphology, proliferation and differentiation capability of UC-MSCs, menstrual blood cells and 
DPSCs were faced. Although UC-MSCs were higher proliferative stem source, DPSCs 
demonstrated lower cellular senescence as well as higher osteogenic capabilities than the other 
two stem cell types (Ren et al., 2016). These results are correlated with the results of the next 
investigation, where the upregulation of growth factor activity, receptor activity and signal 
transduction in DPSCs were demonstrated. In contrast, cell proliferation, immune response and 
angiogenesis related genes were overexpressed in UC-MSCs. In conclusion, UC-MSCs higher 
proliferation was correlated with the overexpression of cell proliferation genes and DPSCs 
lower senescence was correlated with the increase of growth factor activity genes (Kang et al., 
2016). In other research, the differentiation capability was compared between DPSCs, SHEDs, 
BM-MSCs and synovial fluid cells (SFCs), all of them MSCs. Whereas BM-MSCs and SFCs 
showed higher osteogenic and chondrogenic capacity, DPSCs and SHEDs had higher 
neurogenic ability. In the same work SHEDs demonstrated higher proliferation rates compared 
DPSCs and BM-MSCs (Isobe et al., 2016). As was expected due to developmental origin of 
SHEDs, they showed more stem cell markers than DPSCs. In addition, SHEDs had higher 
osteogenic capabilities than DPSCs, but less than BM-MSCs, which also express less stem cell 
markers (Aghajani et al., 2016). iPSCs, are main stem cell source to study neurogenetic 
syndromes.  There are in literature multiple research focused on the efficiency and safety of 
DPSCs reprogramming into iPSCs. It is a fact that DPSCs intrinsically express stem cell 
markers even before to be induce, hence, some authors hypothesize these cells could be more 
efficient source of creating iPSC than cells traditionally used for it (Pisal et al., 2018; Yan et al., 
2010). 
 




1.2.5.4.3Serum-free cultures and dentosphere formation  
Most differentiation treatments consists of fetal serum (bovine or calf) addition in order 
to provide cells proliferation and monolayer adherent growth. The use of serum, committed 
DPSCs to osteo/odontoblastic lineages, following their intrinsic path (Pisciotta et al., 2012; Yu 
et al., 2010). Furthermore, xenogeneic elements could cause immune reactivity and even 
rejection of transplanted cells in cell therapies (Gregory et al., 2006; Horwitz et al., 2002). Since 
MSCs were defined as cell-based medicinal products (CBMPs), DPSCs need to be prepared 
under hard culture measurements in order to achieve good manufacturing practice (GMP) 
required quality standards, as described in EU Regulation 2003/94/EC (Pacini, 2014). Serum 
free medium culture protocols has been studied with the purpose of avoid these problems. Al 
contrary of what showed mDPSCs (Zainal Ariffin et al., 2013) there is no evidence of 
spontaneous osteo/odontoblastic differentiation of human DPSCs (hDPSC). Serum-free based 
studies demonstrated the viability of hDPSCs in this condition as well as the maintenance of 
stem characteristics (Hirata et al., 2010). As we said above the NC origin of hDPSCs grants to 
these cells some special features.  
Although in vitro formation of neurospheres is a singular neural stem/progenitor cell 
characteristic (Pineda et al., 2013), it is not a surprise, due to their EMSCs origin, the capacity 
of hDPSCs to form neurospheres like structures in serum-free conditions, called dentospheres. 
There is a controversy about delicate regulation of dentosphere differentiation ability in 
literature, which is essential to control the role and capacity of DPSCs derived dentospheres. 
Some works describe osteogenic pre-disposition achieved by dentosphere-like DPSCs in serum-
free conditions (Bakopoulou et al., 2017; Bonnamain et al., 2013), while other works defend the 
increase of pluripotential markers in dentospheres increase when DPSCs are cultured in serum-
free medium for several days (Hirata et al., 2010; Lee et al., 2017; Xiao and Tsutsui, 2013). Not 
all the authors are agree on the timing of dentosphere formation during neural differentiation, 
Gervois et al. showed dentosphere formation in the initial differentiation phases, while 
Karbanova et al. demonstrated this formation during late phase. However, both of them as well 
as other several studies suggested a direct link between the differentiation into neural lineages, 
even dopaminergic neuron-like cells were obtained, and the expression of numerous neural 
markers in dentospheres (Chun et al., 2016; Gervois et al., 2015a; Karbanová et al., 2011; 
Osathanon et al., 2014).  
 
 




1.2.5.4.4Neuroprotective and immunomodulative properties of DPSCs 
As important as pluripotent differentiation capability is the expression and secretion 
potential of  nerve growth factor (NGF), brain- derived neurotrophic factor (BDNF), glial cell 
line derived neurotrophic factor (GDNF), neurotrophin 3 (NT-3), vascular endothelial growth 
factor (VEGF) and platelet-derived growth factor (PDGF) showed by DPSCs (Mead et al., 
2014; Sakai et al., 2012).  It is both in vivo and in vitro demonstrated the higher expression of 
these factors by DPSCs compared with BM-MSCs and AT-MSCs (Caseiro et al., 2016). These 
results support the idea of that DPSCs exhibit bigger neuroprotective characteristic to face 
nervous system related affections. It has been described in the literature the importance of these 
factors. For example, some groups have identified the role of trophic factors, i) in the reduction 
of neurodegeneration in the early stages of neural apoptosis and sensory neuron survival (Nosrat 
et al., 2001) or ii) in the promotion of axon regeneration in spite of axonal growth inhibitor 
(Arthur et al., 2009; Kolar et al., 2017) in spinal cord injury (SCI) model. In the same way but 
in ischemic injury of astrocyte model, DPSCs provide both direct and indirect cytoprotection 
(Song et al., 2017). 
Beyond of trophic factor secretion, it has been also documented the importance of 
immunomodulatory and anti-inflammatory factors in DPSCs-based tissue regeneration assays. 
The expression of interleukin-8 (IL-8), interleukin-6 (IL-6), and TGF- β via Toll-like receptor 
(TLR) 4 as well as TGF-β, HGF and indoleamine 2,3-dioxygenase (IDO) by DPSCs has been 
reported (Bianco et al., 2016; Özdemir et al., 2016; Tomic et al., 2011). TGF-β, HGF and IDO  
are able to suppress both the activation of T cells and the proliferation of peripheral blood 
mononuclear cells, even allogeneic immune response was inhibited (Kwack et al., 2017; Sugita 
et al., 2015). In addition, IL-8 preserves axon integrity in SCI crush injury (He et al., 2013). The 
co-culture of DPSCs and T cells resulted in human leukocyte antigen-G, vascular adhesion 
molecule-1, intracellular adhesion molecule-1, IL-6, TGF-β, HGF, and IL-10 secretion. 
Moreover, proinflammatory IL-2, IL-6 receptor, IL-12, IL-17A and tumor necrosis factor-α 
(TNF-α) cytokines were downregulated (Demircan et al., 2011), as well as the proliferation rate 
of T cells was inhibited in 90% (Pierdomenico et al., 2005). In another research, 
intraperitoneally injected DPSCs showed a remarkable modulation effect increasing 
CD4+CD25+FoxP3+ regulatory T cells (Hong et al., 2017). In conclusion, these 
immunomodulatory effects could be a key to create safe and effective allogenic and autogenic 
stem cell therapies. 
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1.2.5.4.5Differentiation of DPSCs 
Due to their EMSC condition, it is not unexpected the relative ease to differentiate 
DPSCs into specialized connective tissue cells, such as adipocytes, chondroblasts and 
osteo/odontoblasts (Gronthos et al., 2002; Kawashima, 2012). However, as already is described 
above, the EMSC origin of DPSCs provide them to become easily into at least two of the three 
germ layer lineage cells, though, they can differentiate into cells of three germ-layers. 
 
Figure 11. DPSCs derived mesodermic and ectodermic cell types (Ibarretxe et al., 2012) 
Ectoderm: Two of the most important advantage of DPSCs compared with other MSCs are the 
neural crest origin and the neuron-like characteristics that facilitate in vitro induction of DPSCs 
into functional neurons. In the last years have been developed many neural differentiation 
protocols. The use of growth factors, neurotrophins and some other small molecules, such as 
fibroblast growth factor (bFGF), epidermal growth factor (EGF), NGF, BDNF, GDNF, sonic 
hedgehog , NT-3, retinoic acid (RA), forskolin and heparin have been necessary in these 
differentiation inductive mediums. Also, B27, ITSx , non-essential amino acids, and N2 culture 
supplements have been commonly used in these protocols (Arthur et al., 2008; Chang et al., 
2014; Gervois et al., 2015a; Kanafi et al., 2014; Király et al., 2011; Osathanon et al., 2014; Xiao 
and Tsutsui, 2013; Zhang et al., 2017) (figure 11 and 12). 
The most of the works above mentioned and the works described in paragraph 1.3.4.3, 
have in common the creation of dentospheres as an essential step in neural differentiation 




protocols. However, some groups have been able to through along this step. Using endogenous 
environmental factors and multistep inductive protocols they achieved specialized motor and 
dopaminergic sub-lineages (Chang et al., 2014; Gnanasegaran et al., 2018; Kanafi et al., 2014). 
Even spiral ganglion neuron-like cells were obtained after BDNF, NT-3 and GDNF treatment of 
DPSCs (Gonmanee et al., 2018). 
Leaving aside typically used neural differentiation confirmation hallmarks, such as 
NeuN, MAP-2, DCX and neural adhesion molecules, few studies used electrophysiological 
assay in order to deepen in functional neural differentiation of DPSCs. However, it is not totally 
clear the genuine neuron differentiation from DPSCs as far as no action potential burst has been 
described, although voltage-gated sodium and potassium functional channel expression have 
been demonstrated (Arthur et al., 2008; Gervois et al., 2015a; Király et al., 2009). 
Several investigations support the idea of either glial or neuronal precursor 
differentiation. Oligodendrocytic differentiation of mDPSCs was used to show the clonal 
heterogeneity into dental pulp, where only nestin positive clones were able to undergo 
differentiation (Young et al., 2016). Genetically modified human DPSCs turn into 
oligodendrocyte progenitor cells after Olig2 gene overexpression (Askari et al., 2014). In 
addition, Martens et al. were able to differentiate DPSCs into functional Schwann cells, which 
could generate myelin sheath around axons in a 3-dimensional collagen type I hydrogel neural 
tissue construct (Martens et al., 2014). 
Mesoderm: The differentiation toward osteoblasts, adipocytes and chondroblasts is one of the 
criterion required by ISCT to consider DPSCs as MSCs (Dominici et al., 2006). 
The osteogenic differentiation has been quite well documented in several researches. 
Like occurs with other differentiation protocols, also osteodifferentiation needs some 
components commonly repeated in almost all receipts. Dexamethasone, L-ascorbic acid and β-
glycerol phosphate are key elements to achieve alkaline phosphatase, collagen type I, 
osteocalcin, osteonectin, osteopontin, osterix and runt-related transcription factor 2 (RUNX2) 
expressing  DPSCs derived osteoblast-like cells (Ajlan et al., 2015; Atari et al., 2012a; Bhuptani 
and Patravale, 2016; Goto et al., 2016; Riccio et al., 2010). Indeed, RUNX2 is one of the most 
important osteo/odontoblastic differentiation regulator. It activates osteoblast gene expression 
and mineralization in the early stages of osteoblast differentiation (Vimalraj et al., 2015; Xu et 
al., 2015b). RUNX2 is also responsible of odontoblastic potential through dentin 
sialophosphoprotein (DSPP) activation, which encodes both dentin sialoprotein and 
phosphoprotein (Han et al., 2014). DSPP and dentin matrix protein 1 (DMP1) upregulated 
expression along with alkaline phosphatase activity increasing are the hallmarks of 
ondotoblastic differentiation (Abuarqoub et al., 2015; Paduano et al., 2016). 
Jon Luzuriaga Gonzalez 
38 
 
There are evidence of adipogenic differentiation of DPSCs by insulin, dexamethasone 
and 3-isobutyl-1-methylxanthine (IBMX) containing inductive medium. Both O staining of lipid 
droplets and the expression of peroxisome proliferator–activated receptor γ, glucose transporter 
type 4, fatty acid binding protein 4 and lipoprotein lipase adipogenic markers are necessaries to 
confirm differentiation (Grottkau et al., 2010; Lee et al., 2015; Zhang et al., 2006). 
Chondroblastic differentiation is given by inductive medium composed of ITSx, 
dexamethasone, L-ascorbic acid, L-proline , sodium pyruvate and TGF-β3 (Hilkens et al., 2013; 
Jang et al., 2016; Nemeth et al., 2014). TGF-β protein superfamily plays an key role in 
chondrogenesis main phases, being the controller of differentiation/de-differentiation activities 
in the cartilage (Dexheimer et al., 2016). 
DPSCs are able to differentiate into less common cell types, such as cardiomyocytes 
(Ferro et al., 2012) and smooth muscle (Song et al., 2016). Endothelial cells were obtained 
culturing DPSCs at least  for 30 days in a-MEM culture medium with 20% (d’Aquino et al., 
2007). Endothelial-like cells were also achieved by Marchionni et al. using DMEM with 2% 









Figure 12. DPSCs derived three germ-layer cell types (Anitua et al., 2018) 
 
Endoderm: Contrary to what was thought years ago, not only ectoderm and mesoderm lineage 
cells could be obtained from hDPSCs. New researches have shed light into pluripotential ability 
of DPSCs. It is confirmed in the last five years, the huge plasticity of these cells, even achieving 
endodermal lineage cell differentiation (figure 12). Hepatic differentiation of human DPSCs was 
successfully demonstrated by the expression of several hepato-specific markers. All these 




investigations were carried on using serum-free or low serum (1%-2%) concentrations 
combined with at least two of the next elements; HGF, ITSx, dexamethasone and oncostatin M  
(Chen et al., 2016; Ferro et al., 2012; Han et al., 2017; Ishkitiev et al., 2012) . Also pancreatic 
cell lineage differentiation has also been reported from human DPSCs. Achieved cells were able 
to produce insulin, glucagon, somatostatin and pancreatic polypeptide as well as the expression 
of pancreatic markers were enhanced. Ishkitiev et al. showed that CD117+ cells were the most 
capable cells to undergo pancreatic differentiation. Moreover,  Yagi Mendoza et al. figured out 
the PI3K/AKT and WNT pathways key role in pancreatic cell differentiation, while Carnevale 
and his group determined that the differentiation began at day 7 (Carnevale et al., 2013; 
Ishkitiev et al., 2013; Yagi Mendoza et al., 2018). 
 
1.2.5.4.6DPSC based regeneration therapies 
Apart of differentiation capability it is must be taking in consideration the 
immunomodulatory, angiogenic and neuroprotective properties of DPSCs (Luo et al., 2018). All 
these features make DPSCs the ideal source to use in regeneration therapies, specifically in 
nerve tissue regeneration due to NC origin shared with PNS cells. Furthermore, vasculogenesis 
may be essential in neural tissue regeneration, providing nutrients and oxygen to injured tissue 
area (figure 13). 
 
Figure 13.  DPSCs and scaffold constructs to application in nervous system diseases (Luo et al., 2018). 
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1.2.5.4.6.1Vasculogenesis and angiogenesis by DPSCs 
Vasculogenesis and angiogenesis are essential processes necessary to create the vascular 
network during embryonic development. Although these two terms often are used like 
synonymous, actually, vasculogenesis is the formation of new blood vessel de novo while 
angiogenesis is the formation of new blood vessels from existing vessels.  Both of them are very 
necessary to maintain normal blood supply needed to maintain normal function of organs and 
tissues (Patan, 2004). Some angiogenic trophic factors are the responsible of creation of new 
blood vessels (Carmeliet, 2000). Like the most of MSCs, it is described the capacity of DPSCs 
to secrete these angiogenic factors; colony-stimulating factor, interleukin-8, angiogenin, 
endothelin-1, angiopoie tin-1, and insulin-like growth factor binding protein-3 (Bronckaers et 
al., 2013; Ratajczak et al., 2016). In combination with secretion of VEGF, PDGF, bFGF, and 
NGF stimulatory growth factors (Mead et al., 2014; Tran-Hung et al., 2008), DPSCs can 
promote tubulogenesis, proliferation and survival of endothelial cells (Tran-Hung et al., 2006). 
Furthermore, Bronckaers et al. discovered that migration and vasculogenesis were activated by 
PI3K/AKT and MEK/ERK pathway of endothelial cells. Taking together the endothelial 
differentiation capability and angiogenic and stimulatory factor expression DPSCs could 
promote therapeutic angiogenesis (Psaltis et al., 2008). Even in 1999 Takahashi et al. began to 
use stem cells and EPCs to stimulate vasculogenesis in order to treat ischemic disease 
(Takahashi et al., 1999). Then, in 2008, rat DPSCs were transplanted into myocardial infarction 
(MI) model. The formation and function of new blood vessels were improved and the infarct 
size reduced by presence  of DPSCs (Gandia et al., 2008). Three years later, focal cerebral 
ischemia rat model was injected with porcine cd31-/cd146- DPSCs, resulting in vasculogenesis 
induction and ameliorated ischemic brain injury after middle cerebral artery occlusion ( MCAO) 
(Sugiyama et al., 2011). One of the few studies focused in human DPSCs in rodent ischemia 
model suggested the paracrine dependent effect of DPSCs in post-stroke recovery, given 
importance to non-neural replacement therapies (Leong et al., 2012). Also the combination of 
DPSCs with HUVECs, showed the formation of microvessel-like formation, which suggests 
that DPSCs could act as perivascular cells for in vivo angiogenesis (Nam et al., 2017). Recently, 
the use of new 3D print top technique has facilitated the creation of vascularized dentin/pulp 
structure (Hilkens et al., 2017). 
 
1.2.5.4.6.2Neural regeneration by DPSCs 
Neuroregeneration therapies have ever been a priority research due the social, economic 
and dependency burden suffered by both patients and their close people. The use of NSCs 
should be crucial in nerve tissue regeneration therapies, however, the low incidence of these 




cells in adult organism as well as obtaining difficulties force researchers to find new stem cell 
sources. Taking in consideration the large amount and relatively easy access to them, MSCs 
have been selected as ideal source to fill the hole left by NSCs (Kerkis et al., 2006; Kim et al., 
2012). Nevertheless, not all MSCs are optimal for these purpose, in fact, DPSCs have the 
needed properties, such as, embryonic pluripotent and neural  stem cell markers, NC origin, 
neural differentiation ability and they can be harvested from the own patient without harmful 
intervention. Furthermore, although DPSCs are less abundantly available compared with other 
MSCs, they present higher proliferation rates (Gronthos et al., 2000). Moreover, using own cells 
of the patients to use in autologous therapy, it possible to avoid immune reactivity, which could 
be a fatal event in neural tissue. Several investigations have been carried on in both central 
nervous system (CNS) and peripheral nervous system (PNS). Some of them are based in cell-
cell substitution, but overall, these researches are secretome-based cell therapies. 
 
1.2.5.4.6.2.1Central nervous system (CNS) 
Central nervous system is the organ that integrate environmental signals and controls 
and coordinates the response for them. It is composed by brain and spinal cord. Stem cell 
treatment as novel CNS disease therapy is already a reality (Tatullo et al., 2015; Varga and 
Gerber, 2014). The low precursor cell population (Mead et al., 2017), expression of myelin-
associated growth inhibitory factors (Geoffroy and Zheng, 2014) and the intrinsic formation of 
glial scar (Stichel and Müller, 1998), make the repair and regeneration capacity of CNS 
especially weak in front of several insults.  
-Neurodegenerative diseases: Alzheimer´s (AD) and Parkinson´s disease (PD) are the first and 
second commonest age-related neurodegenerative diseases. Both of them have been extensively 
studied and new DPSC-based cell therapies have been published in the last years (Apel et al., 
2009). AD is neurodegenerative pathology caused by intracellular neurofibrillary tangles, 
neuronal loss and generation of insoluble peptide deposits. These physiological changes lead to 
well-known symptomatology; that comprehend memory loss, cognitive deficits and linguistic 
disorders, among others (Huang and Mucke, 2012). Both in vivo and in vitro AD models have 
been used to demonstrated the benefit in behavioral and physiological deficits of use DPSCs 
based cell therapies (Apel et al., 2009; Shin et al., 2014). Moreover, other AD disease models 
have been tested. Thus, okadaic acid induced AD was repaired by DPSCs promoted neuronal 
regeneration, microtubule stability protection and maintaining cytoskeletal structure (Wang et 
al., 2017a). Two researches pointed that DPSCs demonstrated high secretion of VEGF, 
fractalkine, RANTES, and fms-related tyrosine kinase 3, seem to be important in the reduction 
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of amyloid beta (Aβ) peptide-induced cytotoxicity and apoptosis (Ahmed et al., 2016; Mita et 
al., 2015).  
DPSCs have been broadly used to dopaminergic (DA) neuron obtaining in vitro (Chang 
et al., 2014; Gnanasegaran et al., 2018; Kanafi et al., 2014). Parkinson´s disease (PD) 
progressive neurodegeration results in loss of DA neurons of nigrostriatal pathway. The loss of 
DA neurons causes bradykinesia, resting tremor, muscle rigidity and postural instability in 
patients (Dauer and Przedborski, 2003).  Like it is described with other CNS affections, DPSCs 
showed anti-inflammatory activity is a key in damaged tissue recovery. Thus, intrathecal 
transplantation of DPSCs into 1-methyl-4-phenyl-1,2,3,6-tetrahydropyri- dine- (MPTP) induced 
old-aged PD mouse model achieved behavioral deficits recovery and DA function restoring by 
upregulation of IL2, IL4, and TNF-β anti-inflammatory factors, while the secretion of pro-
inflammatory factors IL-1α, IL- 1β, IL6, IL8, and TNF-α were reduced (Gnanasegaran et al., 
2017a). Also in vitro, MPTP associated deficits were reduced by neuroimmunomodulatory 
activity of DPSCs (Gnanasegaran et al., 2017b). In addition, a different PD model deficits, in 
this case a model created by 6-hydroxydopamine (6-OHDA) both in vitro (Chun et al., 2016; 
Nosrat et al., 2004) and in vivo (Fujii et al., 2015), were solved by DPSCs promoting of DA 
neurons survival. 
-Stroke: It is defined as blood supply interruption or reduction of the brain, which deprives brain 
tissue and could cause either brain death, long-term disability, even the death (Sughrue et al., 
2004). The interest in this affection is huge since it is the second leading cause of preventable 
death in worldwide and the fourth leading cause of lost productivity  in 2012 (Kuklina et al., 
2012). Damages undergone by brain during long interval of starving could be irreversible. 
Moreover, sadly there are few effective restorer therapies (Hossmann, 2006). Nowadays, the use 
of stem cells in this therapies seems optimistic due to the special properties showed by these 
cells (Lemmens and Steinberg, 2013). In regard to the use of DPSCs, some in vivo works 
demonstrated the therapeutic effectiveness of DPSCs injection into focal ischemic areas of 
MCAO in rats, either by cell-cell DA neurons substitution (Yang et al., 2009) or by trophic 
secretion (Sugiyama et al., 2011). Recently published research work shows how the intravenous 
administration of combination of rat DPSCs and BDNF in MCAO model rats can lead 
neurological function  more effectively compared with either BDNF or DPSCs injection alone 
(Zhang et al., 2018b). Apart from neuronal replacement, song et al. showed the importance of 
secreted anti-inflammatory and trophic factors, using both DPSCs and conditioned medium of 
DPSCs to human astrocyte cytoprotection in model of oxygen-glucose deprivation (OGD) 
ischemia in in vitro (Song et al., 2015). 




-SCI: SCI can cause partial or complete loss of sensory and motor control of the body 
depending on injury severity and location. World health organization (WHO) estimates that 
between 250 000 and 500 000 people suffer this affection every year, in 2018. SCI can divided 
in two independent physiopathologic intervals. The first comprehend nerve and vascular tissue 
destruction, and the second one, which causes neuro-inflammatory responses  such as, 
excitotoxicity, apoptosis, oxidative stress, glial scar formation) (Jiang et al., 2014). NC origin 
and ectomesenchymal properties have made DPSCs very popular in SCI therapies. DPSCs have 
shown the ability to differentiate in both neuron and oligodendrocyte-like cells that provide a 
new source of cell to avoid initial primary tissue disruption (Yamamoto et al., 2014a, 2014b). In 
the same way, DPSCs can attack inflammatory secondary injury, reducing progressive 
hemorrhagic necrosis related with IL-1β, ras homolog gene family member A (RhoA), and 
expressing sulfonyl-urea receptor1 (SUR1) that leads axonal regeneration by neurotrophic 
factors production (Nosrat et al., 2001; Yang et al., 2017). Combining DPSCs with chitosan, 
SCI derived cell apoptosis was inhibited and motor functional recovered (Zhang et al., 2016a).  
-Retinal Injury: Photoreceptors, bipolar cells and retinal ganglion cells (RGCs) create the retina 
(Ramsden et al., 2013). Several affections can cause retinal injuries, such as, traumatic optic 
neuropathy (TON) and degenerative RGCs damaging glaucoma (Munemasa and Kitaoka, 
2015). The low production of neurotrophic growth factors and axonal growth inhibitory 
molecules avoid retinal regeneration (Berry et al., 2008). To face it, use of DPSCs could provide 
the necessary factors to active patients own retinal neural survive and DPSCs neural 
differentiation toward both RGCs-like (Roozafzoon et al., 2015) and photoreceptors (Bray et al., 
2014) in vivo. Indeed, Mead et al. intravitreally transplanted DPSCs after optic nerve injury in a 
rat model caused NGF, BDNF, and NT-3 related axonal recovery along with RGCs 
neuroprotection were reported (Mead et al., 2013). Also, glaucoma was attenuated per 35 days 
after DPSCs intravitreal transplantation by preventing RGCs death (Mead et al., 2016). 
 
1.2.5.4.6.2.2Peripheral nervous system (PNS) 
PNS is divided into the cranial nerves, from III to XII, and the nerves supplying upper 
and lower limbs. They work as the link between CNS and limbs and organs (Catala and Kubis, 
2013). Peripheral nerve injury and diseases often outcome in physical disability and neuropathic 
pain. Treatments that contemplate end-nerve suturing, tissue grafts and growth-stimulatory 
therapies are current clinical treatments (Battiston et al., 2005; Matsuyama et al., 2000; Pfister et 
al., 2011).  Autologous nerve grafting is considered the gold standard for peripheral nerve long 
gap deficits (Tamaki et al., 2016). Autografting related disadvantages, donor nerve availability 
and morphometric mistakes can be solved combining nerve tissue engineering and stem cell 
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therapies (Pereira et al., 2014). Sasaki et al. achieved injured facial nerve regeneration and 
functional recovery using DPSCs (Sasaki et al., 2011). Another two similar  researches showed 
regeneration of sciatic nerve after treatment with collagen conduits filled with Schwann-like 
cells derived from DPSCs (Martens et al., 2014; Sanen et al., 2017). Even genetically 
transformed DPSCs could act as functional oligodendrocytes in vitro and promoted peripheral 
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Alizarin Red assay  
 To test osteogenic potential after three weeks of 
culture, extracellular calcified bone matrix deposits were stained using Alizarin Red. Briefly, 
hDPSCs were fixed for 30 minutes with 10 % formaline (#F7503, Sigma, St. Louis, MO, USA), 
rinsed and stained using 2 g/100 ml Alizarine Red S (#400480250, Fisher Scientific, Hampton, 
Nou Hampshire, USA), pH 4.3 for 45 minutes. After three PBS rinses of 5 min, Alizarin Red 
absorbance was measured at 450 nm using a Synergy HT Multi-Mode Microplate Reader 
(Biotek,Winooski, Vermont, USA). 
Animals and cell graft 
Consanguine c57bl6 litters from Nesti-GFP mice and Athymic Swissnu/nu were used as hosts for 
murine and human in vivo graft purposes. Nestin-GFP neurospheres or DPSCs dentospheres in 
the active growth phase were disaggregated, washed and collected in Neurocult serum-free 
media. Two microliters containing 100,000 cells were injected (0.5 µL/min) unilaterally at the 
following coordinates (from bregma): AP = −1.9, L = −1.2, and DV = −2 and −2.1. The cell 
transplantations were performed using a small animal stereotaxic apparatus (Kopf model 900) 
with a 10 µl Hamilton syringe and a 33 G needle (Hamilton, Bonaduz, Switzerland). All 
surgical procedures were performed under anesthesia with ketamine (75 mg/kg, Imalgen; 
Merial,Lyon, France) and medetomidine (1 mg/kg, Domitor; Pfizer, Paris, France). After the 
surgery, paracetamol (1.64 mg/mLDoliprane; Sanofi, France) was administered in the drinking 
water for 1 week. Animals were provided with food and water ad libitum and housed in a 
colony isolator maintained at a constant temperature of 19–22 °C and humidity (40–50%) on a 
12:12 h light/dark cycle. The animal experiments were performed in compliance with the 
European Communities Council Directive of November 24, 1986 (86/609/EEC) and were 
approved by the competent authority (Administración Foral de Bizkaia).  
 
Conventional PCR and quantitative real-time PCR (qPCR) 
cDNA (20 ng/µl) was obtained by reverse transcription of total extracted RNA using 
iScript cDNA Kit (BioRad, 1708890), using the following reagents: iScript reverse 
Transcriptase (1µl), 5x iScript Reaction Mix (4ul) and Nuclease Free water (variable), obtaining 
a final volume of 20 µl. To perform comparative gene expression assays, a cDNA volume of 10 
µl was used as a template for conventional PCR using My TaqTM Red Mix (Bioline, BIO-
25043), at a 4 ng/µl concentration. The molecular length of the amplification products were 
checked by electrophoresis in a 2 % agarose gel. Quantitative Real-Time PCR experiments were 
performed in CFX96 touch real-time Detection System (BioRad) with Power SYBR® Green 
PCR Master Mix 2x (4367659, Applied Biosystems TM). Experiments were carried out using 0.5 
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µl Primer and 3 ng/µl sample concentration. The molecular weights of the amplification 
products were checked by electrophoresis in a 2 % agarose gel. All reactions were performed in 
triplicate and the relative expression of each gene was calculated using the standard 2-ΔΔCt 
method. Primer pairs used were obtained through either the Primer-Blast method (Primer Bank) 
or other publications. 
Flow cytometry 
Half-million DPSCs were enzymatically disaggregated and then incubated in PBS 
0.15% bovine serum-albumin (BSA) solution with CD90-FITC 1:50 (Biolegend, San Diego, 
California, USA), CD105-PE 1:50 (eBioscience,Waltham, Massachusetts, USA), CD73-APC 
1:50 (eBioscience,Waltham, Massachusetts, USA), CD45-APC 1:50 (Biolegend, San Diego, 
California, USA) or IgG2a κ Isotype control (Biolegend, San Diego, California,USA) for 40 
minutes on ice. Then, DPSCs were washed with PBS 0.15% BSA after staining, then cells were 
resuspended in 300 µl of PBS 0.15% BSA and analyzed using a FACS Beckman Coulter 
Gallios (Beckman Coulter Life Sciences, Indianapolis, United States). Flowing Software 2.5 
(University of Turku, Finland) was used for data analysis. 
hDPSC isolation and culture 
Primary hDPSCs were isolated from human third molars from healthy donors between 
15 and 40 years of age, who gave their informed consent. Teeth were fractured mechanically, 
and the dental pulp enzymatically digested by 3 mg/ml collagenase and 4 mg/ml dispase 
(ThermoFisher Scientific, Waltham, Massachusetts, USA) for 1h at 37 ºC. After centrifugation 
at 15000 rpm for 5 minutes, cells were mechanically dissociated by 18G needles (BD 
Microlance). Then DPSCs were grown in different culture mediums depending on our interests. 
DMEM:  Then, DPSCs were cultured in Dulbecco’s modified Eagle´s medium (DMEM, Lonza, 
Basel, Switzerland) supplemented with 10% of inactivated FBS (Hyclone, GE Healthcare Life 
Sciences, Logan. UT, USA), 2 mM L-glutamine (Sigma, St. Louis, MO, USA) and penicillin 
100 U/ml + streptomycin antibiotics 150 µg/ml (Gibco, Karlsruhe, Germany). Culture media 
were renewed every 2-3 days. Using this protocol, hDPSCs were maintained in optimal 
conditions even up to 3 months, with a total accumulation of 6 passages as maximum. It is the 
optimal medium to cell proliferation and maintainance. 
StemPro MSC SFM™ : Once the DMEM+FBS 10% culture was in confluence hDPSCs were 
subcultured in well defined culture medium named STP for one week, which was composed of 
StemPro MSC SFM basal medium (Gibco, Karlsruhe, Germany) supplemented with StemPro 
MSC SFM supplement (Gibco, Karlsruhe, Germany) at 9:1 ratio and in presence of antibiotics 
penicillin 100 U/ml and streptomycin 150 µg/ml (Gibco, Karlsruhe, Germany). 




StemPro MSC SFM™ + DBDNF/NT3: After 1 week of culture, the STP medium was replaced 
with STP+NTP medium, consisting in the same formulation described above with the addition 
of 500 ng/ml BDNF (Peprotech, London, UK) and 20 ng/ml NT-3 (Peprotech, London, UK). 
Cells are grown in this medium for 7 days at maximum. 
Neurocult™ proliferation: DPSCs were cultured in Neurocult™ proliferation medium after 
enzimatical disossiation for 7 days.  The dentospheres here achieved had the capacity to provide 
more self-renewing cells in each passage. Human Neurocult medium composed of Human 
Neurocult NS-A basal medium (cat# 05750, Stem Cell Technologies, Vancouver, Canada) with 
Neurocult proliferation supplement (cat# 05753, Stem Cell Technologies, Vancouver, Canada) 
at 9:1 ratio, and supplemented with Heparin solution 2 µg/ml (cat# 07980, Stem Cell 
Technologies, Vancouver, Canada), b27 without VitA, EGF 20 ng/ml and FGFb 10 ng/ml 
(Peprotech, London, UK) as previously described in presence of antibiotics penicillin 100 U/ml 
and streptomycin 150 µg/ml (15140-122, Gibco).  
hDPSCs differentiation protocols  
The initial seeding for all conditions was 15000 cell/cm2 using non-coated or coated 
cover slips.  
Osteogenic differentiation: These cells were first cultured in DMEM+10% FBS, STP, 
STP+NTP. Then, culture media were rinsed and changed to DMEM+10% FBS, 20 µM β-
glycerol-phosphate (Sigma, G9422, St. Louis, MO, USA), 10 nM dexamethasone (D4902, 
Sigma, St. Louis, MO, USA), and 52 nM ascorbic acid (#100468, Merck, Darmstadt, Germany) 
for three weeks. 
 
Neurogenic differentiation: Neurogenic induction was achieved using Neurocult™ medium 
with differentiation supplement at 9:1 ratio (Stem Cell Technologies, Vancouver, Canada), 
Heparin at 2 µg/ml (Stem Cell Technologies, Vancouver, Canada), EGF at 20 ng/ml, FGFb at 
10 ng/ml (Peprotech, London, UK), 2% of B27 supplement (Thermofisher, Waltham, 
Massachusetts, USA) and a mixture of antibiotics penicillin/streptomycin at 100 U/ml and 150 
µg/ml respectively (Gibco, Karlsruhe, Germany). DPSCs were grown for at least 7 days in 
laminin coated coverslips. These cells were not grown in other medium before this. 
 
Endotelial differentiation: Our results demonstrated that  DPSCs cultured in human Neurocult 
medium composed of Human Neurocult NS-A basal medium (cat# 05750, Stem Cell 
Technologies, Vancouver, Canada) with Neurocult proliferation supplement (cat# 05753, Stem 
Cell Technologies, Vancouver, Canada) at 9:1 ratio, and supplemented with Heparin solution 2 
µg/ml (cat# 07980, Stem Cell Technologies, Vancouver, Canada), b27 without VitA, EGF 20 
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ng/ml and FGFb 10 ng/ml (Peprotech, London, UK) as previously described in presence of 
antibiotics penicillin 100 U/ml and streptomycin 150 µg/ml (15140-122, Gibco) could be 
differentiated into endothelial cells. These cells were not grown in other medium before this. 
 
Immunostaining of brain sections and cell culture 
Animals were deeply anesthetized with Avertin 2.5 % and transcardially perfused with a 
4 % paraformaldehyde solution in 0.1 M sodium phosphate, pH 7.2 and processed. After post-
fixation overnight at 48ºC, the brains were embedded in agarose and then cut into 20µm 
sections using a VT 1200S vibratome (Leica, France). In order to detect grafted genetically 
unmodified human DPSCs on mice brain, specific antibodies targeted to human Nestin 
(MAB1259, 1:200 R&D systems)49, and human CD31 (BBA7, 1:200 R&D systems) were used. 
Immunostaining of brain vasculature was developed using CD31 (550247, 1:300 BD 
Pharmingen), laminin (L9393, 1:200 Sigma, St. Louis, MO), and VEGF (ABS82-AF647, 1:200 
Sigma, St. Louis, MO) antibodies.  
After a variable days of cell culture, they were fixed by incubation with 4 % PFA for 10 
minutes at room temperature and permeabilized by incubation in 0.1 % Triton X-100. They 
were then incubated overnight at 4 ºC with primary antibodies at the following dilutions: Glial 
Fibrillary Acidic Protein (GFAP) (MAB3402, 1:400; Millipore, Lake Placid, NY), Nestin (NES, 
1:200 Aves Labs), S100ß (Z0311, 1:1000, Dako, Glostrup, Denmark), NeuN (EPR12763, 
1:200; Abcam, Cambridge, UK), Doublecortin (DCX) (sc-8066, 1:200; Santa Cruz, Dallas, TX, 
USA), CD31 (550247, 1:300 BD Pharmingen, San Jose, CA , USA), Anti-STAT3 (phospho 
Y705) antibody (1:500, ab76315, Abcam), anti-human-CD31 (1:200, F8402, Sigma St. Louis, 
MO), VEGF (ABS82-AF647, 1:200 Sigma, St. Louis, MO) and laminin (L9393, 1:200 Sigma, 
St. Louis, MO). For both tissue sections and cell culture, secondary antibodies conjugated to 
Alexa 488, 568 and 647 Donkey anti-mouse, anti-rabbit or anti-goat were incubated for 2 h and 
30 min respectively at room temperature. Preparations were counterstained with DAPI and 
images were captured using a Leica SP8 confocal microscope at 40X magnification. 
 
Live cell calcium imaging 
hDPSCs were grown on glass coverslips and allowed to grow and make contacts for 7 
days. In order to register cell calcium imaging, 5 µM fura-2/AM or 2 µM fluo-4/AM 
(Invitrogen, Waltham, Massachusetts, USA) were incubated for 60 minutes at 37 ºC. 
Immediately, coverslips were placed in a flow chamber (Warner Instruments) with constant 
perfusion of Hank`s balanced salt solution (HBSS, Invitrogen, Waltham, Massachusetts, USA) 
supplemented with 10 mM Hepes (2-[4-(2-hydroxyethyl) piperazin-1-yl] ethanesulfonic acid) at 




room temperature. Then, cells were alternately excited at 340 and 380 nm for fura-2 imaging, 
recording the emitted light above 510 nm. The F340/380 ratio was used as index of cytoplasmic 
[Ca2+]. For fluo-4 imaging, single excitation at 488 nm and emission at 520 nm was used and 
data were plotted as ΔF/F, where ΔF =F-F0. F is the fluorescence intensity of agonist-containing 
solution and F0 is the fluorescence intensity of control solution. Recordings were performed 
using a C10600-10B Hamamatsu camera installed on an Olympus IX71 microscope. Data 
analysis was performed using manually selected regions of interest (ROI), including 
background subtraction using Fiji software. Results are based on recordings from hDPSCs of 3-
4 patients cultured in different culture mediums. 
NSCs culture 
For NSC cultures isolated from Nestin-GFP mice, dissected hippocampi were removed with ice-
cooled PBS-sucrose and either plated in 6 well-plates or T25 low attachment flasks  with 
Neurocult complete medium (StemCell) that was supplemented with heparin (2 mg/ml), EGF 
(20 ng/ml; Invitrogen) and FGF2 (10 ng/ml; Invitrogen). Cells were maintained at standard 
conditions in a humidified 37 Cº incubator containing 5% CO2. Neurosphere cultures were then 
passaged every 7 days by enzymatic disaggregation with Accutase (Sigma, St. Louis, MO). 
 
RNA extraction and retrotranscription 
Cell pellets from the different cultures were washed with PBS, trypsinized (T1426, 
Sigma)  and centrifugated at 1500 rpm for 5 min. Then, they were immediately frozen at -80 ºC 
until use. RNA extraction was performed following RNeasy mini kit instructions (Qiagen, 
Hilden, Germany). RNA concentration was determined using Nanodrop Synergy HT (Biotek, 
Winooski, Vermont, USA) and purity was calculated by 260/280nm absorbance ratio. RNA 
retrotranscription to synthetize cDNA was performed starting from 1000 ng of the total 
extracted RNA using iScript cDNA Kit (1708890, Biorad, Hercules, California) following 
manufacturer instructions. 
 
Statistical analyses  
All results are presented as mean ± standard error, also referred as SEM. Statistical 
comparisons were performed employing Mann Whitney U test, Student’s t-test, Kruskal Wallis 
followed by Dunn´s post hoc test or a one-way ANOVA followed by Bonferroni and Scheffe 
post-hoc tests. Statistical tests were performed by IBM SPSS Statistics v.22. Statistical 
significance was considered to be *p ≤ 0.05, ** p ≤ 0.01, ***p ≤ 0.001. Comparisons between 
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multiple groups were made using The number of independent experiments is shown in the 
respective section. 
Western blot 
Cells were counted and resuspended in a ratio of 20,000 cells /µl of RIPA lysis buffer 
(R0278, Sigma, St. Louis, MO) supplemented with protease (11873580001; Roche) and 
phosphatase inhibitors (78420; Thermo Scientific) to ensure the same cellular concentration for 
the different type of cells and culture media. From this, thirty micrograms of protein was diluted 
in RIPA buffer supplemented with LDS Sample Buffer (NP0007; Invitrogen by Life 
technologies). Then, samples were heated for 5 min at 95Cº and loaded into NuPAGE 4–12% 
Bis-Tris gels (NP0322BOX; Novex by Life Technologies). For electrophoresis, NuPAGE 
running buffer (NP001; Novex by Life Technologies) was used. Protein transfer was performed 
using nitrocellulose membranes (LC2000; Invitrogen by Life Technologies) and NuPAGE 
Transfer Buffer (NP0006-1; Invitrogen by Life Technologies) along with XCell Sure Lock 
Electrophoresis machine (NP0007, Novex, Life Technologies). Phosphorylated-ERK and total 
ERK antibodies (both 1:1000, #4370 and #4695 respectively, Cell Signaling Technologies) and 
phospho-Stat3 and Stat3 (both 1:1000, #9145 and #9132 respectively, Cell Signaling 
Technologies) were used to detect the angiogenic signaling pathways and Ponceau staining 











































































The angiogenic, immunomodulatory, anti-inflammatory, neuroprotective and 
pluripotent differentiation characteristics make the use of MSCs based therapies in the ideal cell 
source for neuroregeneration assays. However, FBS containing proliferative and differentiation 
mediums do not complete the demands GMP requirements to use these cells in human cell 
neuroregenerative therapies. In addition, the most of MSCs show two inconvenience to use 
them in neuroregenerative cell therapies. 1)do not keep close relationship with ectoderm germ 
layer, the origin of neural cells, which means a necessity to undergo a lineage trans-
differentiation to achieve neurogenic fate, and 2) often is needed an invasive intervention to 
acquire them. 
Thus, our hypothesis defend that, NC origin and ectomesenchymal properties of DPSCs 
would provide more effective and safe neurogenic differentiation protocol in serum-free culture 
mediums. Altogether, with the high accessibility, we think that DPSCs are the best option to 










































































































The main objective of this work has been the design of serum-free, safe, effective and 
transplantation permissive, neural differentiation protocols with the aim to assess the neurogenic 




1. Ectomesenchymal characterization of DPSCs cultured in serum-free STP, specific stem 
mesenchymal culture medium. 
2. Comparison of the main morphological and proliferative features between DPSCs 
cultured in DMEM + FBS 10% and serum-free STP. 
3. Test the functionality of the main expressed neurotransmitter and voltage dependent 
calcium channels in both DMEM + FBS 10% and serum-free STP. 
4. Creation of new neurodifferentiation protocol using newly discovered properties 
promoted by serum-free STP. 
5. Assessment of the neuro/glio-genic potential of DPSCs when they are pre-cultured in 
different mediums. 
6. Evaluation of both ectomesenchymal, endothelial and neuro/glio-genic potential in 
Neurocult proliferation™, specific proliferation medium for NSCs. 
7. Evaluation of both ectomesenchymal, endothelial and neuro/glio-genic potential in 
Neurocult differentiation ™, specific differentiation medium for NSCs. 
8. Evaluation of in vivo histo-integration, neuro/glio-genic and vasculogenesis potential of 






















































Results and Discussion 
 
Chapter I: Dental pulp stem cells as a multifaceted tool for bioengineering and the 
regeneration of craniomaxillofacial tissues. (Review). 
Chapter II: Human dental pulp stem cells grown in neurogenic media differentiate into 
endothelial cells and promote neovasculogenesis in the mouse brain. (Research article). 
 
Chapter III: BDNF and NT3 reprogram human ectomesenchymal Dental Pulp Stem Cells to 






















































Neural tissue related affections embrace from neurodegenerative diseases, such as AD 
and PD, to stroke and traumatic injuries. Every year, between 250 000 and 500 000 people 
suffer SCI around the world according to World Health Organization (WHO). The high 
incidence, the lack of effective treatment, the invalidating being and derived economic and 
social burden of the aforementioned diseases (Lopez, 2011) , create a primordial necessity to 
develop and design new neuroregenerative therapies.  
Last years, several works have described the use of stem cells in innovative regeneration 
strategies of disrupted and degenerated nerve tissue. The use of genuine NSCs as precursor of 
newly generated neural cells should be the best way to nerve fiber reconstruction (Steward et 
al., 2013). However, the poor amount of NSCs present in adult human body and the high 
difficulty to access to NSCs location niches, turn these cells in useless for realistic autologous 
cell therapies. 
MSCs have been described as the one of the most available and well-known stem cells 
in adult human body. They can be isolated from umbilical cord, bone marrow, adipose tissue 
and dental structures, among others (El Omar et al., 2014).  Despite of existing SCI reparation 
effective therapies with conventional mesenchymal stem cells (Vaquero et al., 2018), the 
importance of DPSCs in neuroregeneration has been increasing since few years ago. The NC 
origin shared with PNS, the ectomesenchymal features, as well as low invasive extraction 
procedure, draw DPSCs as very compatible source to innovative regeneration approaches 
(Aurrekoetxea et al., 2015). 
The culture of human DPSCs has gone hand in hand with FBS supplementation, that is 
composed of not stablished nutrients, factors and elements of animal origin. The use of serum in 
cultures of human DPSCs provides high proliferation rates and allows long duration cultures. 
However, the cell culture supply with 10-20% FBS is also related with of mesenchymal stem 
cell phenotype promotion. Furthermore, previous works describe the tendency of human DPSCs 
to spontaneously differentiation into osteo/odonto-blasts after expose them to relatively high 
FBS concentrations for long periods (Pisciotta et al., 2012; Yu et al., 2010). In addition, several 
side effects such as allergies and immune reactions  are related with the use of xenogenic serum 
(Gregory et al., 2006; Horwitz et al., 2002). These serum related issues, make FBS useless for 
human neuroregeneration therapies. 
This research work has focused on design, development and test of serum-free commercial 
culture mediums in order to obtain cells that could be used in human neuroregenerative cell 
therapies.  
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We use in our hDPSCs cultures NeurocultTM and StemPro MSCTM (STP) serum free 
culture mediums instead of serum containing common used DMEM+ FBS 10-20%.  Both 
NeurocultTM and STP are genuinely employed in specific cell type cultures. Thus, NeurocultTM is 
currently used in NSCs and progenitor culture in vitro, while STP is especially formulated for 
human mesenchymal stem cell expansion.  
The use of serum-free media is not yet broadly expanded to cell cultures, isolation or 
differentiation of hDPSCs. However, the few works published using serum-free mediums shed 
some light in innovative culture and differentiation protocols for hDPSCs. Thus, according to 
the results we obtained in our separate works where NeurocultTM and STP were used as culture 
mediums (chapter II and chapter III, results and discussion), Hirata et al. firstly mentioned the 
maintenance of hDPSC in serum-free media (Hirata et al., 2010). We showed that also 
proliferation ratio was decreased in both NeurocultTM and STP, likely due to replace of FBS. In 
addition, our group carried out the characterization of phenotypic change of hDPSCs into 3D-
like spheroid structures. These non-adherent spheroids-like structures, termed dentospheres, are 
pretty similar to that spheroids, called neurospheres, generated by NSCs and NCSCs in vitro 
(Fournier et al., 2016; Lee et al., 2007a; Reynolds and Weiss, 1992b). Although the generation 
of spheroid –like structures in serum-free conditions by hDPSCs totally agrees with the 
publication of Bonnamain et al. where similar results were described, the efficiency of 
dentosphere generation seems to be higher in our both works. We achieved almost 100% of 
dentosphere creation efficiency compared with low 30% ratio described by Bonnamain et al. 
(Bonnamain et al., 2013). 
  Even if we have demonstrated in each work (chapter II and chapter III, results and 
discussion) that depending on culture conditions cell growth and some marker expression can be 
changed, analysed hDPSCs demonstrated almost indentical expression of mesenchymal and 
neural stem/neural crest stem markers. All three analyzed proliferation culture mediums; 
NeurocultTM proliferation, STP and DMEM + FBS 10%, unexpectedly expressed almost similar 
mesenchymal stem surface markers CD73, CD90 and CD105 ( data not shown to neurocult 
proliferation). In addition, Nestin and GFAP were presented in similar values  in analysed 
hDPSCs cultured in all culture mediums, even in cultures of NSCs. All these markers together 
comprehend the common marker pattern showed by NC-derived mesenchymal stem cells. There 
is described the presence of NC progenitors located in perivascular niches within dental pulp 
(Janebodin et al., 2011; Kaukua et al., 2014).  NCSCs can be commited to either to neural 
lineage forming  neuronal and glial cells of  PNS or to ectomesenchymal lineage to form special 
connective tissue that will generate the most of maxillofacial structures in embryonic 
development (Aurrekoetxea et al., 2015).  




Once we achieved NC-derived EMSCs dentospheres in NeurocultTM, we realized the 
potential applications of these cells in neuroregenerative therapies. The employment of STP, 
specialized human mesenchymal stem cell culture medium, seemed to be logical for this 
purpose. We did not only improve our NCSCs obtaining efficiency using STP, but also 
achieved more pure NCSCs rather than already committed neural or endothelial progenitors 
discovered using NeurocultTM. 
Despite of the similarity of the dentospheres created by hDPSCs cultured in Neurocult 
proliferation and STP, these two protocols provide different special characteristic to hDPSCs. 
On the one hand, surprisingly, we discovered the overexpression of mRNA levels of NTRK2 
and NTRK3 when hDPSCs were grown in STP. These two receptors belong to Tyrosine Kinase 
activity receptors and are involved in neural stem cell physiological and cellular activities, such 
as differentiation and neuronal survival among others (Bibel and Barde, 2000; Oliveira et al., 
2013).  To our knowledge, we are one of the first groups demonstrating the expression of these 
receptors in hDPSCs. 7 days after exposure of BDNF and NT3, respective ligands of 
NRTK2/TrkB and NRTK3/TrkC, to that cells cultured preliminarily in STP, the role of NTRK2 
and NTRK3 in homeostasis and differentiation of hDPSCs was proposed. The physiological and 
molecular modifications; proliferation increase, common stem pluripotency core factors 
NANOG, SOX2 and OCT4a overexpression and NC HNK1 and p75NTR progenitor markers 
overexpression promoted by exogenous neurotrophins, made us to suggest a step back in 
DPSCs lineage, reprogramming them toward genuine NCSCs. 
On the other hand, hDPSCs grown in NeurocultTM proliferation did not show 
aforementioned NCSCs-like modifications apart from markers they expressed basally. 
However, they were able to express VEGF and CD31 endothelial markers in proliferation 
conditions either in suspension or in laminin promoted adhesion, suggesting some type of 
differentiation or selection. 
Likely, phenotypic similarity with NCSCs is also present in hDPSCs grown in DMEM+ 
FBS 10%, but according  to Xiao and Tsutsui the dentospheres could be composed by different 
mature and progenitor cells at first. However, the hermetic structure of dentosphere that avoids 
the needed oxygenation, along with the starving caused by serum-free condition promote the 
death of committed mature cells while time goes by. In fact, neural progenitors and stem cells 
can survive, and even hDPSCs stemness is enhanced in hypoxic conditions  (Xiao and Tsutsui, 
2013). 
One of the aims seeked in neuroregeneration therapies is the restoration of neuronal 
cells lost after a tissue injurie or pathology. The multiple connections created by  large quantity 
of neuronal cells showed by human adult nervous systems turn the neurogeneration in a tough 
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challenge for researchers. In overall, we have demonstrated with those works, the capacity of 
hDPCSs to differentiate into neuronal and glial cells after grown in serum-free conditions. 
Depending on culture medium, the differentiation can be indirect or  direct.  
Like it is commented above, when hDPSCs were seeded in BDNF and NT-3 containing STP 
medium for 7 days it seemed to be a dedifferentiation procces, were NCSCs-like cells were 
achieved.  In order to confirm the functional reprogramming of ectomesenchymal hDPSCs into 
early NC precursors we tested the capacity of these cells to derive into neural cells. It is 
described that differentiation fate can be switch depending on serum absence or presence. In 
fact, serum presence enhance the ectomesenchymal being of NCSCs, as we concluded with our 
hDPSCs grown in DMEM+FBS 10% (Lee et al., 2007a).  The hDPSCs pre-exposed to FBS and 
then seeded in both DMEM+ FBS 10% and in STP were still remaining mesenchymal being, 
once BDNF and NT-3 addited, this characteristic was changed and NC and pluripotency 
markers were overexpressed, that are related with stemness increase (Uribe-Etxebarria et al., 
2017). The genuine characteristics of both NC early precursors and ectomesenchymal cells, 
provide them the ability to differentiate into different type of cells .Thus, we saw the loss of 
capacity of BDNF/NT-3 treated hDPSCs to give rise osteoblasts or mineralized bone matrix in 
osteoinductive medium, however,  hDPSCs exposed to DMEM+FBS 10% for long period 
seemed to be preconditioned to osteogenic fate. Moreover, not only mesenchymal comitting 
was decrease in neurotrophin treated hDPSCs, but they significantly increase the neurogenic 
potential once they were cultured in NeurocultTM differentiation neuroinductive medium. 
Compared with the hDPSCs of the same donor grown in DMEM+FBS 10%, neuronal (NeuN, 
DCX) and glial (p75NTR, S100β) marker expression were five times increased each. Supported 
by these results, we can say that we firstly design a culture protocol able to increase very 
functional NCSCs population from not genetically or epigenetically modified hDPSCs. This 
could be described as an indirect neurogenic differentiation, given the need for several steps to  




















Figure 1. Graphical abstract of “BDNF and NT3 reprogram  human ectomesenchymal Dental 
Pulp Stem Cells to neurogenic and gliogenic Neural Crest progenitors cultured with serum free 
medium” (chapter III ). 
In the case of hDPSCs cultured in NeurocultTM differentiation medium, that is a specific 
variant of NeurocultTM proliferation medium to differentiate NSCs into mature cells, showed 
almost the same neurogenic capability shown by NSCs. After 1 week of culture of hDPSCs in 
neurocult differention serum-free medium, supplemented with B27 with vitA, hDPSCs began to 
express neuronal markers NeuN and DCX. In the same way, these cells expressed GFAP and 
S100b glial markers. There were not statistical significance difference with the marker 
expression values showed by NSCs. These results suggest direct neurogenic potential of 
hDPSCs cultured in NeurocultTM differentiation (figure 2). 
It is widely accepted the role of substitutive neuronal cells in neuroregenerative 
therapies, however, some neurological affections are not directly derived of neuronal cells loss, 
but they are caused by irrigation problems. Thus, since Takahashi et al. employed EPCs and 
stem cells for first time to vasculogenesis stimulation in ischemic disease (Takahashi et al., 
1999), the importance of angiogenesis and vasculogenesis have been taken importance in some 
neural afections, such as ischemia, and MI, among others (Tatullo et al., 2015).  In addition to 
already confirmed neurogenic potential, we wanted to asses the endothelial differentiation 
potential of hDPSCs. Despite of the existance of previous works that achieve endothelial 
vascular cells either they were cultured in 10% serum presence in the case of hDPSCs, or the 
serum-free protocol was optimized for non-human cells (d’Aquino et al., 2007; Weiss et al., 
1990). We have been the first group able to derive non-genetically modified endothelial 
vascular cells from hDPSCs in serum free conditions. Although we achieved neurogenic cells 
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after neural induction using NeurocultTM differentiation medium, we realized that we could 
achieve VEGF and CD31, endotelial markers, expressing hDPSCs using NeurocultTM 
proliferation supplemented with B27 without vitA, EGF and bFGF. We also reported both the 
activation of  STAT3 and ERK in NeurocultTM proliferation medium and the out standing role of 
them in endothelial differentiation. Our results totally correlate with the results of other groups, 
that support the importance of ERK in angiogenesis (Xu et al., 2008) and the relation of 
phosphor-STAT3 with VEFG overexpression (Niu et al., 2002), and endothelial cell activation 
(Chen et al., 2008). Furthermore, Bento et al. related the differentiation of SHED toward 
endothelial cells by ERK activation with the VEGF dependant VEGFR2 enhancement (Bento et 
al., 2013). Taking in consideration all the results obatined we concluded that we were able to 










Figure 2. Graphical abstract of “human dental pulp stem cells grown in neurogenic media 
differentiate into endothelial cells and promote neovasculogenesis in the mouse brain” (chapter 
II). 
Like is commented several times during this work, there are a large amount of works in 
the literature were is given more weight to neuroprotective activity than to the cell-cell neuronal 
restoration (Ratajczak et al., 2016; Song et al., 2017). In accordance to Mead et al. we also 
characterized the expression of NGF, BDNF and NT-3 (Mead et al., 2014). 
All the results obtained in vitro seems to be very hopeful to translation of these 
protocols to cell therapies in human. However, the employment of these cells in in vivo models 
could be totally change the approach. In fact, although hDPSCs were able to express neuronal 
and glial markers in vitro when were grown in NeurocultTM differentiation, they were previously 




grown in NeurocultTM proliferation to expand, we could not find any neural marker after 
intracranial graft of hDPSCs in vivo. Probably due to specific immune system that eliminated all 
the neuro-differentiated hDPSCs (data not shown). On the other hand, after one month of post-
intracranial graft into athymic nude mice we found CD31+ Nestin+ VEGF+ hDPSCs. Nestin 
(Suzuki et al., 2010), VEGF (Ferrara et al., 2003) and laminin (Malinda et al., 2008) increased 
expression are taken as angiogenesis hallmark. Moreover, laminin is 50% decreased in ageing 
related issues  (Gavazzi et al., 1995) and it can downregulate TGF-β in epithelial cells (Streuli et 
al., 1993), that is involved neurogenic niche quiescence during ageing (Pineda et al., 2013). In 
addition, the capacity to depolymerization of amyloid  fibrils, the laminin degradation in 
cerebral ischemia and laminin variation during CNS injuries, make us to realize about the 
importance of laminin. Accordingly, hDPSCs disaggregated from dentospheres and then grafted 
into the brain of immunosuppressed mice, could be advantageous in rejuvenating therapies and 
neurodegenerative illnes (Bronfman et al., 1996; Fukuda et al., 2004; Ji and Tsirka, 2012). 
In the case of hDPSCs grown in STP, we needed to asses their histointegration capacity, 
as far as this is the ability of cells to adapt to new enviroment. The creation of new functional 
interactions and the ability to exchange information with hostage tissue is key to a correct 
function and good engrafment of foreign cells (Guerzon et al., 2011; Muschler et al., 2004). The 
aforementioned NCSC character of hDPSC is given by the addition of BDNF and NT-3, 
common elements released in the nervous system. More than the engrafment of already NCSCs-
like reprogrammed hDPSCs, would be better to engraft hDPSCs genuinely grown in STP. Thus, 
we could elude the use of exogenous neurotrophins, activating overexpressed NTRK2 and 
NTRK3 by endogenous neurotrophins. Neurotransmitters are the main elements used in the 
intercelullar communications in nerve tissue. For example both GABA and glutamate are 
determinant in the creation of synaptic connectiosn during development (Ben-Ari, 2001; 
Egorov and Draguhn, 2013). The characterization of the possible responses given by hDPSCs 
to different neurotransmitters was essential to know the capacity of these cells to interact with 
hostage tissue and, therefore, to coordinately communicate to provide a common function of the 
tissue. Suprinsingly, we found that except to P2XR7, a purinergic receptor tested by ATPyS 
agonist, more expressed in STP conditions, both DMEM+ FBS 10% and STP expressed 
similarly different subunits of ionotropic neurotransmitter receptors. Moreover, the stimulation 
of hDPSCs by certain agonists were clearly demonstrated by microfluorescence calcium assays. 
Apart from neurotransmitter receptors hDPSCs of two culture conditions expressed also several 
groups of Connexins (Cx26, Cx43) and Pannexin (Pnx1) subunits, that are responsibles of Ca+2 
propagation, a special characteristic of neural tissue during development (Bruzzone et al., 2003; 
Harrison et al., 2007; Nadarajah et al., 1997; Ray et al., 2005). We also confirmed the presence 
of functional Bay-K-sensitive L-type voltage dependent calcium channels, that were described 
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for first in hDPSCs by Ellis et al  (Ellis et al., 2014). All these elements are necessary to good 
integration in nervous tissue, that make gDPSCs ideal to regeneration therapies. 
To sum up, all these results here gathered not only suggest the good viability of human 
DPSCs in different serum-free mediums, but also means that these mediums can promote 
physiological, molecular and functional changes in the cells that could be interesting to use in 
neuroregeneration assays. Furtheremore, the clear neurogenic and endothelial differentiation 
potential, neuroprotective cues expression along with the integration and neovacularization of 
human DPSCs in the mouse brain are the needed requirements (Luo et al., 2018) to open the 
window of a new generation of tissue regeneration cell therapies, apart from nervous system 
related tissues also, even in pathologies of non-nerve tissues .  
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The use of innovative new serum-free culture mediums has resulted in the discovery of 
new physiological, molecular and behavioral features in hDPSCs that clearly suggest the high 
capacity of these cells to differentiate into neurogenic lineage cells. The neuroprotective and 
vasculogenic properties also remark the importance of DPSCs in neural regeneration cell 
therapies. 
The following conclusions have been drawn from the results obtained in this work: 
1. The culture of hDPSCs in serum-free STP, does not affect the ectomesenchymal 
characteristic expression compared with those grown in DMEM + FBS 10%. They 
remain expressing neural stem, mesenchymal and pluripotent markers in STP.  
2. While hDPSCs cultured in DMEM + FBS 10% grow in monolayer, hDPSCs cultured 
in serum-free STP are able to generate neurospheres-like dentosphere 3D structures. 
Proliferation rate of  hDPSCs cultured in DMEM + FBS 10% is significantly higher 
than the rate showed by these cells grown in STP, that showed quiescence-like stage, 
likely promoted by serum absence.  
3. All tested neurotransmitter receptors and voltage dependent calcium channels have 
shown to be functional in both DMEM + FBS 10% and serum-free STP. 
4. NTRK2 and NTRK3, neurotrophin receptor are overexpressed in the cells cultured in 
serum-free STP. 
5. Adding BDNF and NT3, respectively the natural ligands of NTRK2 and NTRK3, in a 
serum-free STP, termed as STP + NTF2, NC and pluripotential markers are 
overexpressed. These results suggest the lineage step -back to NCSCs from hDPSCs, 
after passing out quiescence stage showed by cells cultured in genuine STP. 
6. The hDPSCs cultured in STP + NTF2, show remarkable higher neurogenic ability 
than those cells cultured in both genuine STP and DMEM- FBS 10%. 
7. hDPSCs cultured in Neurocult proliferation™, are able to generate dentospheres and 
express both stem mesenchymal and endothelial markers. 
8. While hDPSCs cultured in neurocult differentiation™ are able to express neuronal and 
glial markers, they do not express endothelial markers. 
9. The engraftment of hDPSCs pre-cultured in serum-free neurocult proliferation™ into 
mice brain, showed the ability to generate de novo vasculature in brain. Suggesting 









































































I Patent: Organ and tissue revascularization by dental origin cells 
transplantantion (2018) 
 
 
 
 
 
 
